var title_f2_36_2624="Kleihauer-Betke stain for fetal hemoglobin";
var content_f2_36_2624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Kleihauer-Betke stain for fetal hemoglobin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arrow points to the typical dark pink fetal red blood cell. Note the \"ghost\" maternal red cells in the background, a result of the instability of hemoglobin A at acidic pH.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2624=[""].join("\n");
var outline_f2_36_2624=null;
var title_f2_36_2625="Dry AMD with atrophy";
var content_f2_36_2625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F79129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F79129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dry type ARMD with drusen and chorioretinal atrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The bright yellow drusen are coalescing, and a large area of atrophy is seen in the macula (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from the Massachusetts Eye &amp; Ear Infirmary, Photographer, David Walsh.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2625=[""].join("\n");
var outline_f2_36_2625=null;
var title_f2_36_2626="Modified Mallampati airway classification";
var content_f2_36_2626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 586px\">",
"   <div class=\"ttl\">",
"    The modified Mallampati classification for difficult laryngoscopy and intubation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 566px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The modified Mallampati classification",
"    <sup>",
"     1",
"    </sup>",
"    is a simple scoring system that relates the amount of mouth opening to the size of the tongue, and provides an estimate of space available for oral intubation by direct laryngoscopy. According to the Mallampati scale, class one is present when the soft palate, uvula, and pillars are visible, class two when the soft palate and base of the uvula are visible, class three when only the soft palate is visible, and class four when only the hard palate is visible.",
"    <br>",
"     <br>",
"      <sup>",
"       1",
"      </sup>",
"      Samsoon GL, Young JR. Difficult tracheal intubation: a retrospective study. Anaesthesia 1987; 42:487.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2626=[""].join("\n");
var outline_f2_36_2626=null;
var title_f2_36_2627="RLL BAC CT";
var content_f2_36_2627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59100%7EPULM%2F70885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59100%7EPULM%2F70885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchioloalveolar carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with the consolidative form of bronchioloalveolar carcinoma in the right lung. CT scan shows a mass in the posterobasal and laterobasal segments of the right lower lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchioloalveolar carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal view of PET scan shows intense uptake of FDG in the right lower lobe. The left sided activity in the left ventricle (arrow) is normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2627=[""].join("\n");
var outline_f2_36_2627=null;
var title_f2_36_2628="Indirect immunofluorescence antiribosomal P autoantibodies";
var content_f2_36_2628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F59670&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F59670&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Indirect immunofluorescence using the HEp-2 cell substrate and human serum containing antiribosomal P autoantibodies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The antibodies produce a finely-speckled cytoplasmic staining pattern (green, panel A). DAPI staining in panel B (blue) indicates the location of nuclei. Merge of panels A and B is shown in panel C.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Bloch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2628=[""].join("\n");
var outline_f2_36_2628=null;
var title_f2_36_2629="Antithymocyte globulin (rabbit derived, Thymoglobulin): Drug information";
var content_f2_36_2629=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Antithymocyte globulin (rabbit derived, Thymoglobulin): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?18/48/19204?source=see_link\">",
"    see \"Antithymocyte globulin (rabbit derived, Thymoglobulin): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/1/7189?source=see_link\">",
"    see \"Antithymocyte globulin (rabbit derived, Thymoglobulin): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F135993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Thymoglobulin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F136005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Immune Globulin;",
"     </li>",
"     <li>",
"      Immunosuppressant Agent;",
"     </li>",
"     <li>",
"      Polyclonal Antibody",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F135994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Treatment of acute rejection: I.V.: 1.5 mg/kg/day for 7-14 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F136002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/1/7189?source=see_link\">",
"      see \"Antithymocyte globulin (rabbit derived, Thymoglobulin): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F135995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F639201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     WBC count 2000-3000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or platelet count 50,000-75,000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Reduce dose by 50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     WBC count &lt;2000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or platelet count &lt;50,000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Consider discontinuing treatment",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F135985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thymoglobulin&reg;: 25 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F135975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F135987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The first dose should be infused over at least 6 hours through a high-flow vein. Subsequent doses should be administered over at least 4 hours. Administer through an in-line 0.22 micron filter. Premedication with corticosteroids, acetaminophen, and/or an antihistamine may reduce infusion-related reactions.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F12996420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Variable (consult detailed reference):",
"     </b>",
"     Heparin, hydrocortisone sodium succinate.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F135986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acute rejection of renal transplant; used in conjunction with concomitant immunosuppression",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F4801541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Induction therapy in renal transplant; treatment of myelodysplastic syndrome (MDS)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9885364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Antithymocyte globulin rabbit (Thymoglobulin&reg;) may be confused with antithymocyte globulin equine (Atgam&reg;)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F136003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension, peripheral edema, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills, fever, headache, pain, malaise",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperkalemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Leukopenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Antirabbit antibody development, cytomegalovirus infection, sepsis, systemic infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Gastritis, gastrointestinal moniliasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Herpes simplex infection, oral moniliasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Anaphylaxis, cytokine release syndrome, PTLD, neutropenia, serum sickness (delayed)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F135990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to antithymocyte globulin, rabbit proteins, or any component of the formulation; acute or chronic infection",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F135979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylaxis: Hypersensitivity and fatal anaphylactic reactions can occur; immediate treatment (including epinephrine 1:1000) should be available.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cytokine release syndrome (CRS): Release of cytokines by activated monocytes and lymphocytes may cause fatal CRS during administration of antithymocyte globulin. Rapid infusion rates of have been associated with CRS in case reports. Symptoms range from a mild, self-limiting &ldquo;flu-like reaction&rdquo; to severe, life-threatening reactions. Severe or life-threatening symptoms include hypotension, acute respiratory distress syndrome, pulmonary edema, myocardial infarction, and tachycardia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infection: Severe infections may develop following concomitant use of immunosuppressants and prolonged use or overdose of antithymocyte globulin. Appropriate antiviral, antibacterial, antiprotozoal, and/or antifungal prophylaxis is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Malignancy: An increased incidence of lymphoma, post-transplant lymphoproliferative disease (PTLD) or other malignancies may develop following concomitant use of immunosuppressants and prolonged use or overdose of antithymocyte globulin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic toxicity: Reversible neutropenia and thrombocytopenia may result from the development of cross-reactive antibodies. Dose adjustment may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunizations: Patients should not be immunized with attenuated live viral vaccines during or shortly after treatment; safety of immunization following therapy has not been studied.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Administration: Initial dose must be administered over at least 6 hours into a high flow vein; may pretreat with an antipyretic, antihistamine, and/or corticosteroid.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced physician:",
"     <b>",
"      [U.S. Boxed Warning]: Should only be used by physicians experienced in immunosuppressive therapy for the treatment of renal transplant patients.",
"     </b>",
"     Medical surveillance is required during the infusion.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6218046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F639175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F639176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F639177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Thymoglobulin Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (1): $756.22",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F135983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lymphocyte profile, CBC with differential and platelet count; vital signs during administration; signs and symptoms of infection",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      ATG-Fresinius (EE, SE);",
"     </li>",
"     <li>",
"      Thymoglobuline (AU, BG, CL, DK, FI, GB, GR, HK, MY, NO, TH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F135978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Polyclonal antibody which appears to cause immunosuppression by acting on T-cell surface antigens and depleting CD4 lymphocytes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F135989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: Lymphopenia may persist  &ge;1 year",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination, plasma: 2-3 days",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Broliden PA, Dahl IM, Hast R, et al, &ldquo;Antithymocyte Globulin and Cyclosporine A as Combination Therapy for Low-Risk Non-Sideroblastic Myelodysplastic Syndromes,&rdquo;",
"      <i>",
"       Haematologica",
"      </i>",
"      , 2006, 91(5):667-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/36/2629/abstract-text/16670072/pubmed\" id=\"16670072\" target=\"_blank\">",
"        16670072",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hardinger KL, &ldquo;Rabbit Antithymocyte Globulin Induction Therapy in Adult Renal Transplantation,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2006, 26(12):1771-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/36/2629/abstract-text/17125438/pubmed\" id=\"17125438\" target=\"_blank\">",
"        17125438",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10026 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-197.136.42.3-1F4CD360AE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2629=[""].join("\n");
var outline_f2_36_2629=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708632\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135993\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136005\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135994\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136002\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135995\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F639201\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135985\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135975\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135987\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12996420\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135986\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4801541\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9885364\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136003\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135990\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135979\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298764\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6218046\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F639175\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F639176\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F639177\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322995\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135983\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038531\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135978\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135989\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10026\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10026|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/48/19204?source=related_link\">",
"      Antithymocyte globulin (rabbit derived, Thymoglobulin): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/1/7189?source=related_link\">",
"      Antithymocyte globulin (rabbit derived, Thymoglobulin): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_36_2630="Transsexualism: Epidemiology, pathophysiology, and diagnosis";
var content_f2_36_2630=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transsexualism: Epidemiology, pathophysiology, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Louis J G Gooren, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Vin Tangpricha, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Peter J Snyder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Alvin M Matsumoto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2630/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/36/2630/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transsexualism is the condition in which a person with apparently normal somatic sexual differentiation of one gender is convinced that he or she is actually a member of the opposite gender. It is associated with an irresistible urge to be in the opposite gender hormonally, anatomically, and psychosocially. The epidemiology, pathophysiology, and diagnosis of transsexualism will be discussed here. The treatment of transsexualism is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8602?source=see_link\">",
"     \"Treatment of transsexualism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14025196\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gender identity is the sense one has of being male or female [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/1\">",
"     1",
"    </a>",
"    ]. Some people experience a significant incongruence between their gender identity and inborn physical phenotype, labeled as Gender Identity Disorder (GID); the experience is termed gender dysphoria [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/1\">",
"     1",
"    </a>",
"    ]. Living as a member of the opposite biological sex is referred to as transgenderism; this encompasses a wide spectrum. The most extreme expression of this is transsexualism, characterized by an overwhelming desire to undergo phenotypical transition to the subjectively experienced gender by means of hormonal and surgical treatment. Other people with gender dysphoria may seek partial adaptions to the other sex, such as hormonal treatment or forms of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H163867803\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H163867851\">",
"    <span class=\"h2\">",
"     Prevalence of transsexualism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevailing social climate and provisions for medical treatment influence assessments of prevalence data. Further, the definition of the condition, sometimes making no clear distinction between transsexuals and transgender individuals, affects prevalence studies. Some studies identify only subjects who actually undergo",
"    <span class=\"nowrap\">",
"     hormonal/surgical",
"    </span>",
"    treatment, while others determine prevalence data based upon patient self-identification.",
"   </p>",
"   <p>",
"    The prevalence of transsexualism, based on data of subjects undergoing sex reassignment treatment in the Netherlands, is 1:11,900 men and 1:30,400 women [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/4\">",
"     4",
"    </a>",
"    ]. The prevalence is similar in Belgium [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/5\">",
"     5",
"    </a>",
"    ], slightly lower in Sweden, but higher in Singapore. The prevalence by self-report in New Zealand is approximately 1:6000 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/6\">",
"     6",
"    </a>",
"    ]. Apparently, only those for whom gender dysphoria becomes a burden seek medical treatment. An approximate 3:1 ratio of male-to female versus female-to-male transsexuals is widely encountered in the western world, but in other parts of the world female-to-male transsexualism is greater [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. There is no plausible explanation for the variations of sex ratios in different parts of the world. The prevalence of transsexualism appears to be similar over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Sexual differentiation of the brain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, transsexualism has been conceptualized as a purely psychological phenomenon, but research on the brains of male-to-female transsexuals has found that the sexual differentiation of one brain area, the bed nucleus of the stria terminalis, follows a female pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. This area of the brain has been proposed to be important for gender identity and may support a biologic basis for transsexualism.",
"   </p>",
"   <p>",
"    Sexual differentiation in mammals takes place in distinctly different steps, each with a critical period and contingent upon the previous one. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41220?source=see_link\">",
"     \"Normal sexual differentiation\"",
"    </a>",
"    .) From studies in rats, mice, and other lower mammals, it appears that the brain undergoes a sexual differentiation process, similar to those of the internal and external genitalia. Sexual differentiation of the brain depends upon the presence or absence of androgens. In the presence of androgens prenatally or perinatally, male brain differentiation occurs and, in their absence, female brain differentiation occurs.",
"   </p>",
"   <p>",
"    There is also some evidence that sexual dimorphism of the brain exists in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sex differences in size and shape of certain nuclei in the hypothalamus have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/11\">",
"       11",
"      </a>",
"      ]. One of the sexually-dimorphic nuclei becomes differentiated between the ages of two and four [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/11\">",
"       11",
"      </a>",
"      ], while the sexual differentiation of the bed nucleus of the stria terminalis may extend into adulthood [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/14\">",
"       14",
"      </a>",
"      ].",
"      <strong>",
"      </strong>",
"      The time of differentiation of the other sex-dimorphic nuclei is not known.",
"     </li>",
"     <li>",
"      In a sample of male-to-female transsexuals, the bed nucleus of the stria terminalis showed all characteristics of a female differentiation [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. In the brain of a single female-to-male transsexual, a male differentiation was found [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Longer androgen receptor gene CAG trinucleotide repeats are associated with reduced sensitivity of the androgen receptor and one study suggests that androgen receptor gene repeat length polymorphism may be associated with male-to-female transsexualism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/15\">",
"     15",
"    </a>",
"    ]. These findings support the concept of transsexualism as a disorder where the sexual differentiation of the brain is not consonant with chromosomal pattern and gonadal sex [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/16\">",
"     16",
"    </a>",
"    ]. However, these biological findings currently play no role in the diagnosis of gender dysphoria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1529503\">",
"    <span class=\"h2\">",
"     Other influences",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not known if the mechanism controlling sexual differentiation of the human brain is exclusively hormonally determined [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/13,17\">",
"     13,17",
"    </a>",
"    ]. From clinical observations in patients with a disorder of sex development or cross-sex hormone exposure during pregnancy, the evidence for a hormonal mechanism alone is not convincing. Postnatal rearing is likely to be a significant factor in the development of gender identity; this is no longer irreconcilable with the concept of a biological substrate for gender identity, since early life experiences can shape subsequent brain anatomy and function [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/12,18\">",
"     12,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some infants with one gonadal sex are born with the external genitalia of the other. Follow-up studies of these children show that sex of assignment is an important but not the sole prognosticator of future gender identity and role. It has also been thought that gender identity becomes largely fixed around the age of three years. Clinical experience shows, however, that this is not universally the case.",
"   </p>",
"   <p>",
"    Individuals with disorders of sex development may transition to the other sex, which may occur well beyond the age of three years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. It happens mainly in subjects with a degree of prenatal androgen (testosterone) exposure, such as steroid 5-alpha-reductase 2 deficiency. These individuals may develop a male gender identity at puberty, after having been originally assigned to the female sex on the basis of the appearance of their female-looking genitalia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30423?source=see_link\">",
"     \"Steroid 5-alpha-reductase 2 deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30304256\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30304312\">",
"    <span class=\"h2\">",
"     Gender dysphoria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most adult transsexuals recall that their gender dysphoria started early in life, well before puberty. Children with gender identity problems increasingly come to the attention of mental health providers. Prospective and retrospective follow-up studies suggest that gender dysphoria during childhood persists into",
"    <span class=\"nowrap\">",
"     adolescence/adulthood",
"    </span>",
"    in only a minority of children (approximately 15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/22-26\">",
"     22-26",
"    </a>",
"    ]",
"    <em>",
"     .",
"    </em>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/5/12378?source=see_link\">",
"     \"Overview of gender development and clinical presentation of gender nonconformity in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of adolescents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8602?source=see_link\">",
"     \"Treatment of transsexualism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30304445\">",
"    <span class=\"h2\">",
"     Psychiatric comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychiatric comorbidities are common in transsexual individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/27\">",
"     27",
"    </a>",
"    ]. One cross-sectional study reported a lifetime prevalence of psychiatric diagnoses (including mood disorders, anxiety disorders, schizophrenia, substance abuse, and eating disorders) of 71 percent, but a current prevalence of 39 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/28\">",
"     28",
"    </a>",
"    ]. The frequency of psychopathology is lower in individuals who are receiving hormone therapy when compared with those who are not [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mental health provider making the diagnosis of gender dysphoria and transsexualism must, in addition, identify and treat psychiatric conditions before considering hormonal treatment or sex reassignment surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial assessment of a patient for transsexualism is based on psychodiagnostic instruments and is generally done by a mental health professional. Two diagnostic classification systems, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) (until DSM-5 is available) and International Classification of Diseases 10 (ICD-10), have diagnostic guidelines for transsexualism and related gender identity disorders. For clinicians, the best guidance is provided by the standards of care of the World Professional Association for Transgender Health (WPATH) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The current ICD criteria for transsexualism include (",
"    <a class=\"graphic graphic_table graphicRef87417 \" href=\"UTD.htm?43/7/44156\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The desire to live and be accepted as a member of the opposite sex, usually accompanied by the wish to make his or her body as congruent as possible with the preferred sex through surgery and hormone treatments.",
"     </li>",
"     <li>",
"      The presence of the transsexual identity persistently for at least two years.",
"     </li>",
"     <li>",
"      The absence of another mental disorder or a genetic, intersex, or chromosomal abnormality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of transsexualism must first be made before considering hormone and surgical reassignment therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2630/abstract/31\">",
"     31",
"    </a>",
"    ]. In addition, it is essential to identify any comorbid psychiatric diagnosis that may require treatment before considering hormone therapy.",
"   </p>",
"   <p>",
"    Presently, most cases of transsexualism are diagnosed in adulthood, but increasingly children and adolescents with gender dysphoria present for diagnosis and treatment.",
"   </p>",
"   <p>",
"    The clinical presentation of gender nonconformity in children and the management of transsexualism are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/5/12378?source=see_link&amp;anchor=H462800710#H462800710\">",
"     \"Overview of gender development and clinical presentation of gender nonconformity in children and adolescents\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8602?source=see_link\">",
"     \"Treatment of transsexualism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     INFORMATION FOR PATIENTS",
"    </strong>",
"    &mdash; UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/41/7826?source=see_link\">",
"       \"Patient information: Transsexualism (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H330166\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transgenderism is the discrepancy between one&rsquo;s own experience of gender identity and the physical body. There is a wide range of severity of transgenderism. The most extreme form is transsexualism, the condition in which a person with apparently normal somatic sexual differentiation of one gender is convinced that he or she is actually a member of the opposite sex. It is associated with an irresistible urge to be that gender hormonally, anatomically, and psychosocially (see",
"      <a class=\"local\" href=\"#H14025196\">",
"       'Overview'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The pathophysiology of transsexualism and gender dysphoria is unclear. Neither psychological nor biological studies have been able to confirm the underlying risk factors or cause (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The prevalence of transsexualism in people undergoing hormonal and surgical sex reassignment in the Netherlands is 1:11,900 men and 1:30,400 women. Figures from other countries are similar. The figures from clinical samples (persons who undergo",
"      <span class=\"nowrap\">",
"       hormonal/surgical",
"      </span>",
"      sex reassignment) are considerably lower than those from non-clinical samples (people with a degree of gender dysphoria not seeking medical treatment). The 3:1 ratio of",
"      <span class=\"nowrap\">",
"       males/females",
"      </span>",
"      is widely encountered in the western world, but in other parts of the world female-to-male transsexualism is greater (see",
"      <a class=\"local\" href=\"#H163867851\">",
"       'Prevalence of transsexualism'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Psychiatric comorbidities are common in transsexual individuals (see",
"      <a class=\"local\" href=\"#H30304445\">",
"       'Psychiatric comorbidity'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The initial assessment of a patient for transsexualism is based on psychodiagnostic instruments and is generally done by a mental health professional. Two diagnostic classification systems, DSM-IV and ICD, have diagnostic guidelines for transsexualism and related gender identity disorders. Excellent guidance is provided by the standards of care of the World Professional Association for Transgender Health (WPATH) (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/1\">",
"      Brett MA, Roberts LF, Johnson TW, Wassersug RJ. Eunuchs in contemporary society: expectations, consequences, and adjustments to castration (part II). J Sex Med 2007; 4:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/2\">",
"      Cohen-Kettenis PT, Gooren LJ. Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res 1999; 46:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/3\">",
"      Gooren LJ. Clinical practice. Care of transsexual persons. N Engl J Med 2011; 364:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/4\">",
"      van Kesteren PJ, Gooren LJ, Megens JA. An epidemiological and demographic study of transsexuals in The Netherlands. Arch Sex Behav 1996; 25:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/5\">",
"      De Cuypere G, Van Hemelrijck M, Michel A, et al. Prevalence and demography of transsexualism in Belgium. Eur Psychiatry 2007; 22:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/6\">",
"      Veale JF. Prevalence of transsexualism among New Zealand passport holders. Aust N Z J Psychiatry 2008; 42:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/7\">",
"      Vujovic S, Popovic S, Sbutega-Milosevic G, et al. Transsexualism in Serbia: a twenty-year follow-up study. J Sex Med 2009; 6:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/8\">",
"      Okabe N, Sato T, Matsumoto Y, et al. Clinical characteristics of patients with gender identity disorder at a Japanese gender identity disorder clinic. Psychiatry Res 2008; 157:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/9\">",
"      Zhou JN, Hofman MA, Gooren LJ, Swaab DF. A sex difference in the human brain and its relation to transsexuality. Nature 1995; 378:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/10\">",
"      Kruijver FP, Zhou JN, Pool CW, et al. Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab 2000; 85:2034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/11\">",
"      Swaab DF, Chung WC, Kruijver FP, et al. Sexual differentiation of the human hypothalamus. Adv Exp Med Biol 2002; 511:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/12\">",
"      Crespi EJ, Denver RJ. Ancient origins of human developmental plasticity. Am J Hum Biol 2005; 17:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/13\">",
"      Hrabovszky Z, Hutson JM. Androgen imprinting of the brain in animal models and humans with intersex disorders: review and recommendations. J Urol 2002; 168:2142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/14\">",
"      Chung WC, De Vries GJ, Swaab DF. Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood. J Neurosci 2002; 22:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/15\">",
"      Hare L, Bernard P, S&aacute;nchez FJ, et al. Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biol Psychiatry 2009; 65:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/16\">",
"      Gooren L. The biology of human psychosexual differentiation. Horm Behav 2006; 50:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/17\">",
"      Bocklandt S, Vilain E. Sex differences in brain and behavior: hormones versus genes. Adv Genet 2007; 59:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/18\">",
"      McEwen BS. Understanding the potency of stressful early life experiences on brain and body function. Metabolism 2008; 57 Suppl 2:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/19\">",
"      Wilson JD. The role of androgens in male gender role behavior. Endocr Rev 1999; 20:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/20\">",
"      Dessens AB, Slijper FM, Drop SL. Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 2005; 34:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/21\">",
"      Reiner WG. Gender identity and sex-of-rearing in children with disorders of sexual differentiation. J Pediatr Endocrinol Metab 2005; 18:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/22\">",
"      Cohen-Kettenis PT, Delemarre-van de Waal HA, Gooren LJ. The treatment of adolescent transsexuals: changing insights. J Sex Med 2008; 5:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/23\">",
"      Steensma TD, van der Ende J, Verhulst FC, Cohen-Kettenis PT. Gender Variance in Childhood and Sexual Orientation in Adulthood: A Prospective Study. J Sex Med 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/24\">",
"      Wallien MS, Cohen-Kettenis PT. Psychosexual outcome of gender-dysphoric children. J Am Acad Child Adolesc Psychiatry 2008; 47:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/25\">",
"      Drummond KD, Bradley SJ, Peterson-Badali M, Zucker KJ. A follow-up study of girls with gender identity disorder. Dev Psychol 2008; 44:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/26\">",
"      Steensma TD, Biemond R, de Boer F, Cohen-Kettenis PT. Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clin Child Psychol Psychiatry 2011; 16:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/27\">",
"      Murad MH, Elamin MB, Garcia MZ, et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf) 2010; 72:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/28\">",
"      Hepp U, Kraemer B, Schnyder U, et al. Psychiatric comorbidity in gender identity disorder. J Psychosom Res 2005; 58:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/29\">",
"      Smith YL, van Goozen SH, Cohen-Kettenis PT. Adolescents with gender identity disorder who were accepted or rejected for sex reassignment surgery: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 2001; 40:472.",
"     </a>",
"    </li>",
"    <li>",
"     WPATH. Standards of Care. file://www.wpath.org/publications_standards.cfm (Accessed on January 08, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2630/abstract/31\">",
"      Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94:3132.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7454 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-41.78.124.10-00EF7A87C0-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2630=[""].join("\n");
var outline_f2_36_2630=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H330166\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14025196\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H163867803\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H163867851\">",
"      Prevalence of transsexualism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Sexual differentiation of the brain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1529503\">",
"      Other influences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30304256\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30304312\">",
"      Gender dysphoria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30304445\">",
"      Psychiatric comorbidity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H330166\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7454\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7454|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/7/44156\" title=\"table 1\">",
"      Criteria for transsexualism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41220?source=related_link\">",
"      Normal sexual differentiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/5/12378?source=related_link\">",
"      Overview of gender development and clinical presentation of gender nonconformity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/41/7826?source=related_link\">",
"      Patient information: Transsexualism (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30423?source=related_link\">",
"      Steroid 5-alpha-reductase 2 deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8602?source=related_link\">",
"      Treatment of transsexualism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_36_2631="Chapter 6F: Hormonal regulation of calcium and phosphate balance";
var content_f2_36_2631=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 6F: Hormonal regulation of calcium and phosphate balance",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2631/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/36/2631/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The maintenance of calcium and phosphate homeostasis involves changes in intestinal, bone, and renal function. Regulation of intestinal function is important because, in contrast to the complete absorption of dietary NaCl and KCl, the absorption of Ca2+ and phosphate is incomplete. This limitation is due both to the requirement for vitamin D and to the formation of insoluble salts in the intestinal lumen, such as calcium phosphate, calcium oxalate, and magnesium phosphate.",
"   </p>",
"   <p>",
"    As an example, a normal adult may ingest 1000 mg of Ca2+ per day, of which roughly 400 to 500 mg may be absorbed. However, 300 mg of calcium from digestive secretions is lost in the stool, resulting in the net absorption of only 100 to 200 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/1\">",
"     1",
"    </a>",
"    ]. In the steady state, this quantity of calcium is excreted in the urine.",
"   </p>",
"   <p>",
"    Most of the body Ca2+ and much of the phosphate exist as hydroxyapatite, Ca10(PO4)6(OH)2, the main mineral component of bone. Phosphate also is present in high concentration in the cells. Within the plasma, both Ca2+ and phosphate circulate in different forms. Of the plasma Ca2+, roughly 40 percent is bound to albumin, 15 percent is complexed with citrate, sulfate, or phosphate, and 45 percent exists as the physiologically important ionized (or free) Ca2+. Plasma phosphorus, in comparison, consists of phospholipids, ester phosphates, and inorganic phosphates. The latter are completely ionized, circulating primarily as HPO42- or H2PO4- in a ratio of 4:1 at a plasma pH of 7.40. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23224?source=see_link\">",
"     \"Chapter 10B: Buffers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although only a small fraction of the total body calcium and phosphate is located in the plasma, it is the plasma concentrations of ionized Ca2+ and inorganic phosphate that are under hormonal control. This function is mediated primarily by parathyroid hormone and vitamin D, which affect intestinal absorption, bone formation and resorption, and urinary excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. The physiologic roles of other hormones such as calcitonin and estrogens in the regulation of Ca2+ and phosphate balance are incompletely understood and will not be discussed further [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PARATHYROID HORMONE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parathyroid hormone (PTH) is a polypeptide secreted from the parathyroid glands in response to a decrease in the plasma concentration of ionized Ca2+ [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/2\">",
"     2",
"    </a>",
"    ]. This change is sensed by a specific Ca2+-sensing protein in the cell membrane of the parathyroid cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/3,8\">",
"     3,8",
"    </a>",
"    ].The receptor permits variations in the plasma Ca2+ concentration to be sensed by the parathyroid gland, leading to the desired changes in PTH secretion. Polymorphisms of this receptor may underlie a significant portion of the variability observed in the serum calcium concentrations in normal individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/9\">",
"     9",
"    </a>",
"    ], while inactivating mutations lead to hypercalcemia because a higher plasma Ca2+ concentration is required to activate the receptor and suppress PTH release [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=see_link\">",
"     \"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=see_link\">",
"     \"Parathyroid hormone secretion and action\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PTH acts to increase the plasma Ca2+ concentration in three ways (",
"    <a class=\"graphic graphic_algorithm graphicRef76820 \" href=\"UTD.htm?8/48/8972\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the presence of permissive amounts of vitamin D, it stimulates bone resorption, resulting in the release of calcium phosphate.",
"     </li>",
"     <li>",
"      It enhances intestinal Ca2+ and phosphate absorption by promoting the formation within the kidney of calcitriol (1,25 dihydroxycholecalciferol), the major active metabolite of vitamin D (see below).",
"     </li>",
"     <li>",
"      It augments active renal Ca2+ reabsorption.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These effects are reversed by a small elevation in the plasma Ca2+ concentration, which lowers PTH secretion.",
"   </p>",
"   <p>",
"    PTH also influences phosphate balance, although its actions may be offsetting (",
"    <a class=\"graphic graphic_algorithm graphicRef76820 \" href=\"UTD.htm?8/48/8972\">",
"     algorithm 1",
"    </a>",
"    ). It tends to increase phosphate entry into the extracellular fluid by its effects on bone and intestinal absorption. However, PTH also reduces proximal tubular phosphate reabsorption, resulting in enhanced excretion. The urinary effect usually predominates in patients with relatively normal renal function, as PTH tends to lower the plasma phosphate concentration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Renal calcium and phosphate handling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The renal effects of PTH are in part mediated by activation of specific adenylyl cyclase systems in the proximal tubule and the early cortical distal nephron, including the cortical thick ascending limb, the distal tubule, and the connecting segment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/7,13\">",
"     7,13",
"    </a>",
"    ]. Activation of phospholipases C and A2 and the subsequent breakdown of phosphatidylinositol also mediates some of the actions of PTH, particularly the reduction in proximal phosphate reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Stimulation of phospholipase C in the proximal tubule occurs at a lower and more physiologic concentration of PTH than stimulation of adenylyl cyclase [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19988?source=see_link\">",
"     \"Chapter 6A: Mechanisms of hormone action\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PTH diminishes the proximal reabsorption of phosphate by decreasing the activity of the type II Na+-phosphate cotransporter in the luminal membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/14,18,19\">",
"     14,18,19",
"    </a>",
"    ]; as a result, luminal phosphate is less able to enter the cells and be returned to the systemic circulation (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36905?source=see_link&amp;anchor=H8#H8\">",
"     \"Chapter 3B: Primacy of sodium transport in proximal function\", section on 'Phosphate'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In comparison, the stimulatory effect of PTH on Ca2+ reabsorption occurs primarily in the early cortical distal nephron, particularly the distal tubule and connecting segment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. A review of the mechanism by which distal Ca2+ transport is regulated is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/39/19061?source=see_link\">",
"     \"Diuretics and calcium balance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A clinical example of the importance of the interaction between PTH and calcitriol on renal Ca2+ handling occurs in hypoparathyroidism, a disorder in which both PTH and calcitriol levels are reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/7\">",
"     7",
"    </a>",
"    ]. The ensuing decrease in distal Ca2+ reabsorption results in persistent Ca2+ excretion, despite the presence of a plasma Ca2+ concentration that may be below 7.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (normal equals 8.5 to 10.5",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    If calcitriol is given in this setting to raise the plasma Ca2+ concentration, there will still be PTH deficiency and a persistent partial defect in distal Ca2+ reabsorption. As a result, it may not be possible to safely raise the plasma Ca2+ concentration much above 8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    without inducing marked hypercalciuria that can predispose to calcium stone formation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acid-base balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTH also may contribute to the regulation of acid-base balance in the presence of an acid load. A fall in extracellular pH stimulates PTH secretion and the ensuing increase in phosphate excretion can appropriately enhance net acid excretion by buffering secreted H+ ions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. PTH also minimizes the fall in pH by a second mechanism, promoting bone buffering of the excess acid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     VITAMIN D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D3 (cholecalciferol) is a fat-soluble steroid, which is present in the diet and also can be synthesized in the skin from 7-dehydrocholesterol in the presence of ultraviolet light (",
"    <a class=\"graphic graphic_figure graphicRef63249 \" href=\"UTD.htm?1/10/1198\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/1,4,25\">",
"     1,4,25",
"    </a>",
"    ]. The hepatic enzyme 25&ndash;hydroxylase places a hydroxyl group in the 25 position of the vitamin D molecule, resulting in the formation of 25-hydroxyvitamin D or",
"    <strong>",
"     calcidiol",
"    </strong>",
"    .",
"   </p>",
"   <p>",
"    Calcidiol produced by the liver enters the circulation and travels to the kidney, bound to vitamin D binding protein. In the kidney, tubular cells contain two enzymes (1-alpha-hydroxylase and 24-alpha-hydroxylase) that can further hydroxylate calcidiol, producing 1,25 dihydroxyvitamin D (calcitriol), the most active form of vitamin D, or 24,25-dihydroxyvitamin D, an inactive metabolite&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/1,4,5,26\">",
"     1,4,5,26",
"    </a>",
"    ]. Studies in vitamin D-deficient animals suggest that the proximal tubule is the important site of calcitriol synthesis. In contrast, studies in the normal human kidney under conditions of vitamin D sufficiency indicate that the distal nephron is the predominant site of 1-alpha-hydroxylase expression [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;&dagger;Calcitriol can also be synthesized in activated macrophages and thymic-derived lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. This assumes importance in granulomatous diseases, such as active pulmonary sarcoidosis and tuberculosis, and in lymphoma in which overproduction of calcitriol can lead to increased intestinal calcium absorption, hypercalciuria, and hypercalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/31-35\">",
"     31-35",
"    </a>",
"    ]. This effect appears to be mediated by interferon gamma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/36\">",
"     36",
"    </a>",
"    ] and, in tuberculosis, may have a physiologic role in promoting the ingestion and elimination of the tuberculous bacilli by macrophages and minimizing tissue destruction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The formation of calcitriol is primarily stimulated by",
"    <strong>",
"     PTH",
"    </strong>",
"    and",
"    <strong>",
"     hypophosphatemia",
"    </strong>",
"    in an attempt to maintain Ca2+ and phosphate balance [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/1,37\">",
"     1,37",
"    </a>",
"    ]. In comparison, the hepatic production of calcifediol is largely substrate-dependent and is not hormonally regulated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The responsiveness of this system can be modulated by changes in the plasma Ca2+ concentration in that hypercalcemia impairs and hypocalcemia promotes PTH-induced calcitriol production [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/38\">",
"     38",
"    </a>",
"    ]. This interaction is appropriate for the maintenance of Ca2+ balance; the facilitory action of hypocalcemia, for example, results in a greater increment in calcitriol release, thereby promoting return of the plasma Ca2+ concentration toward normal. Excessive stimulation is prevented by the rise in plasma Ca2+ itself and by negative feedback regulation of the 1-alpha-hydroxylase via binding of calcitriol to the vitamin D receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The regulatory role of phosphate is also important, since calcitriol is the primary hormone that responds to changes in phosphate balance. Phosphate depletion tends to raise and phosphate loading to lower renal calcitriol production [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/37\">",
"     37",
"    </a>",
"    ]. The fall in calcitriol levels after a phosphate load protects against hyperphosphatemia by limiting further intestinal phosphate absorption. On the other hand, markedly increased levels of 1-alpha-hydroxylase messenger RNA are found in mice with renal phosphate wasting and hypophosphatemia due to the targeted inactivation of the sodium-phosphate cotransporter gene [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Calcitriol is degraded in part by being hydroxylated at the 24-position by a 24-hydroxylase. The activity of the 24-hydroxylase gene is increased by calcitriol (which therefore promotes its own inactivation) and reduced by PTH (thereby allowing more active hormone to be formed) .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Actions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main action of calcitriol is to enhance the availability of calcium and phosphate both for new bone formation and for the prevention of symptomatic hypocalcemia and hypophosphatemia. This is primarily achieved by increases in bone resorption, intestinal absorption, and renal tubular Ca2+ reabsorption (",
"    <a class=\"graphic graphic_figure graphicRef63249 \" href=\"UTD.htm?1/10/1198\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Some of the bone and renal actions of calcitriol are mediated by PTH, as calcitriol enhances the PTH-induced stimulation of both bone resorption and distal reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/7,20,40\">",
"     7,20,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Calcitriol regulates the plasma Ca2+ concentration in one other way by binding to receptors in the parathyroid gland, leading to a diminution in further PTH production and release [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/17,24,25,37,38,40-44\">",
"     17,24,25,37,38,40-44",
"    </a>",
"    ]. This modulating effect prevents the development of an excessive PTH response. Its physiologic role in normal subjects is uncertain. In patients with chronic renal failure, however, calcitriol deficiency appears to be an important determinant of the associated secondary hyperparathyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26822?source=see_link\">",
"     \"Chapter 6G: Calcium and phosphate metabolism in renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     REGULATION OF PLASMA CALCIUM AND PHOSPHATE CONCENTRATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Figures 4 and 5 (",
"    <a class=\"graphic graphic_figure graphicRef58351 \" href=\"UTD.htm?37/39/38527\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef51724 \" href=\"UTD.htm?34/49/35615\">",
"     figure 3",
"    </a>",
"    ) depict a model for the roles of PTH and vitamin D in the maintenance of the plasma Ca2+ and phosphate concentrations. The plasma Ca2+ concentration, as routinely measured in the laboratory, includes all the Ca2+ in the plasma, of which only about 45 percent circulates in the physiologically important ionized or unbound state.",
"   </p>",
"   <p>",
"    In general, measuring the total plasma Ca2+ concentration is sufficient, since changes in this parameter usually are associated with parallel changes in the ionized concentration. A common exception occurs in patients with hypoalbuminemia in whom the concomitant decrease in ion binding leads to a reduction in the total plasma Ca2+ concentration without change in the ionized form. To correct for this, the measured plasma Ca2+ concentration should be increased by 0.8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    for each 1.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    fall in the plasma albumin concentration (normal plasma albumin concentration equals 4.0 to 5.0",
"    <span class=\"nowrap\">",
"     g/dL).",
"    </span>",
"    If, for example, the plasma concentration of Ca2+ is 7.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    and that of albumin is 2.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (roughly 2.0",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    less than normal), then the corrected plasma Ca2+ concentration would be 7.5 + (2 &nbsp;x &nbsp;0.8) or 9.1",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    which is normal.",
"   </p>",
"   <p>",
"    PTH and calcitriol are essential for the maintenance of the plasma Ca2+ concentration, since their absence is associated with progressive hypocalcemia due to decreases in bone resorption and intestinal absorption and an increase in urinary Ca2+ excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/7\">",
"     7",
"    </a>",
"    ] In addition to their individual effects, both hormones are able to interact so that Ca2+ and phosphate balance can be independently regulated.",
"   </p>",
"   <p>",
"    If, for example, hypocalcemia does occur, there is a direct stimulus to PTH secretion and the subsequent formation of calcitriol&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef58351 \" href=\"UTD.htm?37/39/38527\">",
"     figure 2",
"    </a>",
"    ). PTH increases calcium phosphate release from bone and urinary phosphate excretion, whereas calcitriol augments intestinal calcium phosphate absorption. Both hormones also reduce urinary Ca2+ excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/7\">",
"     7",
"    </a>",
"    ]. The net effect is an increase in the plasma Ca2+ concentration with little change in the plasma phosphate concentration. This sequence is reversed with hypercalcemia or a high Ca2+ diet as both PTH secretion and calcitriol production are diminished.",
"   </p>",
"   <p>",
"    The normal plasma phosphate concentration, measured in the laboratory as the plasma inorganic phosphorus concentration, i.e., the concentration of phosphorus contained in the inorganic phosphates, is 2.5 to 4.5",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    In the presence of dietary phosphate restriction or hypophosphatemia, there is increased gene expression and synthesis of new Na+-phosphate cotransporters, thereby enhancing proximal phosphate reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/45\">",
"     45",
"    </a>",
"    ]. In addition, calcitriol synthesis is directly enhanced [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/37\">",
"     37",
"    </a>",
"    ], increasing intestinal calcium phosphate absorption (",
"    <a class=\"graphic graphic_figure graphicRef51724 \" href=\"UTD.htm?34/49/35615\">",
"     figure 3",
"    </a>",
"    ). The ensuing small rise in the plasma Ca2+ concentration and perhaps a direct inhibitory effect of calcitriol suppress PTH secretion, reducing calcium phosphate release from bone and further lowering urinary phosphate excretion.",
"   </p>",
"   <p>",
"    The net effect of these adaptations is virtual abolition of phosphate excretion in the urine (unless hypophosphatemia is due to phosphate wasting) and an increase in the plasma phosphate concentration toward normal. This response is achieved with only a slight increment in the plasma Ca2+ concentration.",
"   </p>",
"   <p>",
"    The hormonal response to hyperphosphatemia, which most often occurs in renal failure is discussed in the next section. The direct changes in proximal function are the opposite of those induced by phosphate depletion: decreased proximal phosphate reabsorption, due in part to reduced expression of the gene for the Na+-phosphate cotransporter [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2631/abstract/45\">",
"     45",
"    </a>",
"    ], and diminished calcitriol synthesis.",
"   </p>",
"   <p>",
"    This text is continued elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26822?source=see_link\">",
"     \"Chapter 6G: Calcium and phosphate metabolism in renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/1\">",
"      Kumar R. Vitamin D and calcium transport. Kidney Int 1991; 40:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/2\">",
"      Brown EM. PTH secretion in vivo and in vitro. Regulation by calcium and other secretagogues. Miner Electrolyte Metab 1982; 8:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/3\">",
"      Brown EM, Hebert SC. Calcium-receptor-regulated parathyroid and renal function. Bone 1997; 20:303.",
"     </a>",
"    </li>",
"    <li>",
"     Brown, AJ, Dusso, A, Slatopolsky, E. Vitamin D. Am J Physiol 1999; 277;F157.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/5\">",
"      Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989; 320:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/6\">",
"      Holick MF. Vitamin D and the kidney. Kidney Int 1987; 32:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/7\">",
"      Kurokawa K. Calcium-regulating hormones and the kidney. Kidney Int 1987; 32:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/8\">",
"      Brown EM, Hebert SC. A cloned extracellular Ca(2+)-sensing receptor: molecular mediator of the actions of extracellular Ca2+ on parathyroid and kidney cells? Kidney Int 1996; 49:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/9\">",
"      Cole DE, Peltekova VD, Rubin LA, et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1999; 353:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/10\">",
"      Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/11\">",
"      Pollak MR, Chou YH, Marx SJ, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994; 93:1108.",
"     </a>",
"    </li>",
"    <li>",
"     Rose, BD, Hebert, SC. Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. In: UpToDate in Medicine, Rose, BD (Ed), UpToDate, Wellesley, MA, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/13\">",
"      Chabard&egrave;s D, Gagnan-Brunette M, Imbert-Teboul M, et al. Adenylate cyclase responsiveness to hormones in various portions of the human nephron. J Clin Invest 1980; 65:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/14\">",
"      Biber J, Custer M, Magagnin S, et al. Renal Na/Pi-cotransporters. Kidney Int 1996; 49:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/15\">",
"      Dunlay R, Hruska K. PTH receptor coupling to phospholipase C is an alternate pathway of signal transduction in bone and kidney. Am J Physiol 1990; 258:F223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/16\">",
"      Sheu JN, Baum M, Harkins EW, Quigley R. Maturational changes in rabbit renal cortical phospholipase A2 activity. Kidney Int 1997; 52:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/17\">",
"      Murer H, Werner A, Reshkin S, et al. Cellular mechanisms in proximal tubular reabsorption of inorganic phosphate. Am J Physiol 1991; 260:C885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/18\">",
"      Murer H, L&ouml;tscher M, Kaissling B, et al. Renal brush border membrane Na/Pi-cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney Int 1996; 49:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/19\">",
"      Pfister MF, Lederer E, Forgo J, et al. Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem 1997; 272:20125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/20\">",
"      Friedman PA, Gesek FA. Calcium transport in renal epithelial cells. Am J Physiol 1993; 264:F181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/21\">",
"      Gesek FA, Friedman PA. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 1992; 90:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/22\">",
"      Bouhtiauy I, Lajeunesse D, Brunette MG. The mechanism of parathyroid hormone action on calcium reabsorption by the distal tubule. Endocrinology 1991; 128:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/23\">",
"      Cassola AC, Giebisch G, Wang W. Vasopressin increases density of apical low-conductance K+ channels in rat CCD. Am J Physiol 1993; 264:F502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/24\">",
"      Bichara M, Mercier O, Borensztein P, Paillard M. Acute metabolic acidosis enhances circulating parathyroid hormone, which contributes to the renal response against acidosis in the rat. J Clin Invest 1990; 86:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/25\">",
"      Kawashima H, Kurokawa K. Metabolism and sites of action of vitamin D in the kidney. Kidney Int 1986; 29:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/26\">",
"      Takeyama K, Kitanaka S, Sato T, et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 1997; 277:1827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/27\">",
"      Zehnder D, Bland R, Walker EA, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 1999; 10:2465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/28\">",
"      Cadranel J, Garabedian M, Milleron B, et al. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 1990; 85:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/29\">",
"      Dusso A, Finch J, Delmez J, et al. Extrarenal production of calcitriol. Kidney Int Suppl 1990; 29:S36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/30\">",
"      Reichel H, Koeffler HP, Barbers R, Norman AW. Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 1987; 65:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/31\">",
"      Sandler LM, Winearls CG, Fraher LJ, et al. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med 1984; 53:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/32\">",
"      Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest 1996; 109:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/33\">",
"      Kozeny GA, Barbato AL, Bansal VK, et al. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med 1984; 311:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/34\">",
"      Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 1993; 82:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/35\">",
"      Adams JS. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 1989; 18:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/36\">",
"      Dusso AS, Kamimura S, Gallieni M, et al. gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 1997; 82:2222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/37\">",
"      Portale AA, Halloran BP, Morris RC Jr. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 1989; 83:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/38\">",
"      Matsumoto T, Ikeda K, Morita K, et al. Blood Ca2+ modulates responsiveness of renal 25(OH)D3-1 alpha-hydroxylase to PTH in rats. Am J Physiol 1987; 253:E503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/39\">",
"      Tenenhouse, HS, Hoag, HM, Gauthier, C, et al. Effect of Na+-phosphate cotransporter (NPT2) gene knock-out on renal 25-hydroxyvitamin D-1-alpha- and 24-hydroxylase gene expression (abstract). J Am Soc Nephrol 1998; 9:571A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/40\">",
"      Gerblich AA, Genuth SM, Haddad JG Jr. A case of idiopathic hypoparathyroidism and dietary vitamin D deficiency: the requirement for calcium and vitamin D for bone, but not renal responsiveness to PTH. J Clin Endocrinol Metab 1977; 44:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/41\">",
"      Russell J, Lettieri D, Sherwood LM. Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 1986; 119:2864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/42\">",
"      Slatopolsky E, Lopez-Hilker S, Delmez J, et al. The parathyroid-calcitriol axis in health and chronic renal failure. Kidney Int Suppl 1990; 29:S41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/43\">",
"      Slatopolsky E, Weerts C, Thielan J, et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984; 74:2136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/44\">",
"      Bouhtiauy I, Lajeunesse D, Brunette MG. Effect of vitamin D depletion on calcium transport by the luminal and basolateral membranes of the proximal and distal nephrons. Endocrinology 1993; 132:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2631/abstract/45\">",
"      Levi, M, Lotscher, M, Sorribas, V, et al. Cellular mechanisms of acute and chronic adaptation of rat renal Pi transporter to alterations in dietary Pi. Am J Physiol 1994; 267:F90.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7293 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6F9A708CB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2631=[""].join("\n");
var outline_f2_36_2631=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PARATHYROID HORMONE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Renal calcium and phosphate handling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acid-base balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      VITAMIN D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Actions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      REGULATION OF PLASMA CALCIUM AND PHOSPHATE CONCENTRATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7293\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7293|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?8/48/8972\" title=\"algorithm 1\">",
"      Calcium and regulation of PTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7293|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/10/1198\" title=\"figure 1\">",
"      Vitamin D synthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/39/38527\" title=\"figure 2\">",
"      Hormonal response hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/49/35615\" title=\"figure 3\">",
"      Hormone resp hypophosphatemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23224?source=related_link\">",
"      Chapter 10B: Buffers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36905?source=related_link\">",
"      Chapter 3B: Primacy of sodium transport in proximal function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19988?source=related_link\">",
"      Chapter 6A: Mechanisms of hormone action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26822?source=related_link\">",
"      Chapter 6G: Calcium and phosphate metabolism in renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=related_link\">",
"      Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/39/19061?source=related_link\">",
"      Diuretics and calcium balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=related_link\">",
"      Parathyroid hormone secretion and action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_36_2632="Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology";
var content_f2_36_2632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2632/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2632/contributors\">",
"     YC Gary Lee, MBChB, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2632/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2632/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/36/2632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural effusions can develop as a result of over 50 different pleuropulmonary or systemic disorders. The cause of a pleural effusion is not evident following diagnostic thoracentesis in up to 25 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, no universally accepted definition exists for an \"undiagnosed effusion.\"",
"   </p>",
"   <p>",
"    This topic will review the approach to pleural effusions for which the diagnosis is unclear after initial clinical assessment and investigation. The initial assessment of a patient with a pleural effusion is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=see_link\">",
"     \"Imaging of pleural effusions in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12663?source=see_link\">",
"     \"Diagnostic thoracentesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step for the clinician is to revisit the patient's history, paying particular attention to drugs, occupational exposures, risk factors for pulmonary embolism or tuberculosis, and comorbid conditions.",
"   </p>",
"   <p>",
"    A careful drug history may reveal that the patient is taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    , ovarian stimulation therapy, or a drug that can produce a lupus-like syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28168?source=see_link\">",
"     \"Drug-induced lupus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occupational asbestos exposure, which might suggest a benign asbestos pleural effusion, may have occurred many years earlier [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/5\">",
"     5",
"    </a>",
"    ]. Benign asbestos effusions are usually unilateral, exudative, and about a third have an elevated pleural eosinophil count [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many systemic disorders (eg, lupus, hypothyroidism, amyloid, yellow nail syndrome) can cause an effusion and must not be overlooked. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"     \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=see_link\">",
"     \"An overview of amyloidosis\"",
"    </a>",
"    .) Patients with yellow nail syndrome typically have friable, yellow nails that grow slowly, and may also have lymphedema [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Abnormal nail fold capillaroscopy has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pleural fluid may originate from extrapleural sources, most commonly from transdiaphragmatic movement. A detailed history and examination for ascites, urinary tract obstruction, and hepatic and pancreatic diseases are important. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30263?source=see_link\">",
"     \"Hepatic hydrothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TIME COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some effusions resolve spontaneously, but the time required for resolution varies depending upon the underlying etiology. Uncomplicated parapneumonic effusions and effusions from pulmonary embolism, tuberculous pleurisy, and postcardiac injury syndrome may persist for several weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16728?source=see_link\">",
"     \"Pleural effusions following cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malignant pleural effusions, on the other hand, seldom resolve spontaneously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=see_link\">",
"     \"Management of malignant pleural effusions\"",
"    </a>",
"    .) Benign asbestos pleural effusion, rheumatoid pleurisy, and radiation pleuritis often persist for months to years. Other effusions that may persist for years include those caused by lymphatic abnormalities (eg, yellow-nail syndrome and pulmonary lymphangiectasia) and trapped lung [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     REANALYSIS OF PLEURAL FLUID",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pleural fluid should be analyzed carefully: vital diagnostic clues may lie in simple inspection (especially for chylous effusions) or the smell (in urinothorax), but are often overlooked. Most undiagnosed pleural effusions are exudative, because the differential diagnosis of a transudative effusion is limited and the cause can usually be recognized by the clinical presentation (",
"    <a class=\"graphic graphic_table graphicRef54055 \" href=\"UTD.htm?37/9/38045\">",
"     table 1",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef73530 \" href=\"UTD.htm?38/49/39708\">",
"     table 2",
"    </a>",
"    ). A few points are worth noting when categorizing an undiagnosed effusion as a transudate or exudate:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One common problem is that transudative pleural fluid from patients receiving diuretic therapy may have an elevated protein level and be mistakenly classified as an exudate. In such cases, the N-terminal pro-brain natriuretic peptide (NTproBNP) level in the pleural fluid, especially if higher than",
"      <span class=\"nowrap\">",
"       1500pg/mL,",
"      </span>",
"      can be used to determine if the pleural fluid is a transudate [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. NTpro-BNP has been shown to correctly diagnose heart failure as a cause of most effusions that have been misclassified as exudates by Light&rsquo;s criteria and can help avoid repeated invasive investigations in patients with a strong clinical suspicion of cardiac failure [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"       \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"      </a>",
"      .) If NTproBNP is unavailable, the fluid can be considered a transudate if the total protein gradient (serum minus pleural fluid) is greater than 3.1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in a patient with convincing clinical picture of heart failure who is taking diuretics [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Constrictive pericarditis, which can be a sequel of prior cardiac surgery, infection, or remote radiation therapy, can also be difficult to diagnose. The resulting pleural effusion is typically transudative, but can be exudative with effusive constrictive pericarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link\">",
"       \"Constrictive pericarditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Effusions that are classically exudative can be transudative in some cases (eg, malignancy), usually a result of concomitant causes of transudative fluid formation (",
"      <a class=\"graphic graphic_table graphicRef73530 \" href=\"UTD.htm?38/49/39708\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/9,14\">",
"       9,14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"       \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with a lymphocytic effusion, further investigation should be considered for tuberculosis, sarcoidosis, lymphoma, chylothorax, and pseudochylothorax [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/15\">",
"       15",
"      </a>",
"      ]. Flow cytometry may be helpful in the evaluation of pleural lymphoma [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/16\">",
"       16",
"      </a>",
"      ]. Pleural fluid adenosine deaminase may be helpful when tuberculosis is suspected [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/17\">",
"       17",
"      </a>",
"      ]. A meta-analyses of 63 studies showed that pleural fluid ADA level provides 92 percent sensitivity and 90 percent specificity in diagnosing tuberculous pleuritis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/18\">",
"       18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=see_link\">",
"       \"Management of malignant pleural effusions\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TRAPPED LUNG",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of trapped lung should be suspected in any patient with a stable chronic pleural effusion, particularly if there is a history of pneumonia, pneumothorax, thoracic surgery, or hemothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/9\">",
"     9",
"    </a>",
"    ]. A trapped lung occurs when a remote inflammatory process causes a fibrin peel to form on the visceral pleural surface, thereby preventing the lung from expanding to the chest wall. This generates a negative pleural pressure favoring movement of fluid from the parietal pleural capillaries into the pleural space, until a new steady state is reached. Other causes of trapped lung include rheumatoid pleurisy, uremic pleurisy, tuberculosis, and malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9735?source=see_link\">",
"     \"Mechanisms of pleural liquid turnover in the normal state\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=see_link\">",
"     \"Mechanisms of pleural liquid accumulation in disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/62/4072?source=see_link\">",
"     \"Diagnosis and management of pleural causes of unexpandable lung\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/27/4534?source=see_link\">",
"     \"Measurement of pleural pressure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;If clinical examination and pleural fluid analysis fail to result in a diagnosis, additional investigations with imaging and pleural biopsy will be needed. Bronchoscopy is rarely helpful in identifying the cause of an undiagnosed pleural effusion, unless the chest radiograph or computed tomography (CT) show parenchymal abnormalities or the patient presents with hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pleural pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trapped lung can be diagnosed radiologically, or in the appropriate clinical setting, when the decrease in pleural pressure is at least 15 cm H",
"    <sub>",
"     2",
"    </sub>",
"    0 per liter of fluid removed. The initial pleural pressure with a trapped lung is typically negative, but a positive pressure can also be observed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/62/4072?source=see_link\">",
"     \"Diagnosis and management of pleural causes of unexpandable lung\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomographic imaging (CT) of the thorax with pleural phase contrast enhancement should be performed in virtually all patients with an undiagnosed pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/22\">",
"     22",
"    </a>",
"    ]. Irregular or thickened pleura with contrast enhancement suggests pleural inflammation or malignancy and identifies optimal sites for CT guided needle aspiration or cutting needle biopsy. CT may also reveal signs of invasion of underlying or adjacent structures that would suggest malignant pleural disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31382?source=see_link\">",
"     \"Imaging of pleural plaques, thickening, and tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CT pulmonary angiography may be considered if pulmonary embolism (PE) is a consideration. Two studies of 60 and 230 patients with pulmonary emboli showed that 47 to 48 percent had an effusion, the majority of which were small and did not require drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/15,23\">",
"     15,23",
"    </a>",
"    ]. Large effusions should alert clinicians to alternative or additional causes of fluid formation other than pulmonary embolism.",
"   </p>",
"   <p>",
"    Positron emission tomography",
"    <span class=\"nowrap\">",
"     (PET)/CT",
"    </span>",
"    has an emerging role: 18-fluorodeoxyglucose (FDG)-avidity confirms, but cannot differentiate between inflammatory and malignant disease. Focal increased uptake of FDG in the pleura and the presence of solid pleural abnormalities on CT are suggestive of malignant pleural disease. A PET-CT pattern composed of pleural uptake and increased effusion activity had an accuracy of 90 percent in predicting malignant pleural effusions in 31 patients with known extrapulmonary malignancy and a pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/24\">",
"     24",
"    </a>",
"    ]. A negative",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    would favor a benign etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/25\">",
"     25",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    may also highlight extrapleural abnormalities that may be the cause of the effusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pleural biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural biopsy typically follows CT scan in undiagnosed pleural effusions. A number of techniques for pleural biopsy are available.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Percutaneous techniques include closed pleural biopsy and CT guided cutting needle biopsy. The former is useful primarily when diseases such as tuberculosis are suspected (eg, because of a lymphocytic effusion or risk factors for TB). Ultrasound guidance can improve the yield of percutaneous biopsy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/26\">",
"       26",
"      </a>",
"      ]. CT guided biopsy is useful when a pleural based mass is visible [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Thoracoscopic pleural biopsy is increasingly used to diagnose malignancy when an obvious mass is not visible on CT, when percutaneous biopsy is negative, or when patchy disease is suspected [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Open pleural biopsy by thoracotomy has been used in the past, but has been largely replaced by thoracoscopic pleural biopsy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Closed pleural biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closed pleural biopsy is useful in conditions where the pleura is diffusely involved (eg, TB pleuritis or non-caseating granulomata in rheumatoid pleuritis), but less so if involvement is patchy (eg, pleural malignancies). It can be considered in the setting of an undiagnosed lymphocytic effusion, particularly if the percentage of lymphocytes is greater than 80 percent.",
"   </p>",
"   <p>",
"    Closed pleural biopsy of the parietal pleura with a Cope or Abrams needle is operator-dependent. In a retrospective analysis of 75 patients who underwent percutaneous pleural biopsy, sufficient pleural tissue was obtained from 72 percent of patients when three samples were obtained, which increased to 80 percent with four to six samples [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/30\">",
"     30",
"    </a>",
"    ]. For all diagnoses, the sensitivity, specificity, positive predictive value, and negative predictive values were 38, 100, 100, and 51 percent, respectively. Pneumothorax complicated 11 percent of procedures.",
"   </p>",
"   <p>",
"    The initial pleural biopsy in tuberculous pleuritis is positive in approximately 70 percent of cases. A greater number of biopsies taken at a single session (6 or more), or multiple, separate biopsy procedures can increase the sensitivity to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/31\">",
"     31",
"    </a>",
"    ]. The combination of pleural fluid adenosine deaminase level and closed pleural biopsy may be adequate to establish a diagnosis of pleural tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     CT guided cutting needle biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT guided cutting needle biopsy is typically used to diagnose malignancy when pleural based soft tissue masses are identified by CT scan. In a randomized trial, CT guided biopsy had a sensitivity of 87 percent (versus 47 percent with Abrams needle biopsy) in patients with suspected malignant effusions with negative cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/27\">",
"     27",
"    </a>",
"    ]. In another study of 85 cases, the sensitivity and specificity were 76 and 100 percent, respectively, for image guided biopsy for pleural malignancies. A pneumothorax occurred in only 4 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Thoracoscopic pleural biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracoscopic pleural biopsy, in the form of video assisted thoracoscopic surgery (VATS) or pleuroscopy (also called medical thoracoscopy) has a diagnostic yield for malignant pleural effusions that is superior to percutaneous pleural biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/32,34,35\">",
"     32,34,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41414?source=see_link\">",
"     \"An overview of medical thoracoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/59/42933?source=see_link&amp;anchor=H2#H2\">",
"     \"Indications for diagnostic thoracoscopy\", section on 'Pleural effusion of unknown etiology'",
"    </a>",
"    .) It should be noted that a negative thoracoscopic biopsy does not fully exclude malignant pleural disease. False negative (around 8 percent) can occur, especially with mesothelioma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/2,36\">",
"     2,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TUBERCULOUS PLEURISY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous pleurisy affects all age groups and should not be overlooked [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/37\">",
"     37",
"    </a>",
"    ]. An initial negative skin test does not exclude the diagnosis of pleural tuberculosis; the need for further diagnostic procedures in this setting is dictated largely by the likelihood of tuberculosis exposure.",
"   </p>",
"   <p>",
"    Elevated levels of pleural fluid adenosine deaminase and interferon-gamma increase the likelihood that a lymphocytic effusion is due to TB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/38\">",
"     38",
"    </a>",
"    ]. Empiric treatment for tuberculosis may be considered in selected PPD positive patients with an undiagnosed, lymphocyte-predominant exudate and no alternative likely etiology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22261?source=see_link&amp;anchor=H5#H5\">",
"     \"Tuberculous pleural effusions in HIV-infected patients\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=see_link&amp;anchor=H3577153#H3577153\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of the pleural effusion may become obvious with long-term follow-up, though most cases remain of unknown etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/2,39-41\">",
"     2,39-41",
"    </a>",
"    ]. One study monitored 143 patients who had a non-diagnostic pleural fluid analysis and pleural biopsy. Follow-up ranging from one to six years revealed that 29 (20 percent) had malignancy, and one had tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/39\">",
"     39",
"    </a>",
"    ]. However, another study found neither malignancy nor tuberculosis during a mean follow-up of 33 months in 53 patients with nonspecific pleuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/40\">",
"     40",
"    </a>",
"    ]. In a retrospective study of 83 patients with undiagnosed \"idiopathic\" effusions, 47 resolved, 20 improved, and 16 persisted during follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/41\">",
"     41",
"    </a>",
"    ]. Biochemical pleural fluid analysis did not predict these outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/41\">",
"     41",
"    </a>",
"    ]. During follow-up, particular attention is paid to identifying &lsquo;treatable&rsquo; causes of a pleural effusion (eg, TB, lymphoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Overall, patients with idiopathic pleural effusions generally have favorable outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2632/abstract/2,41\">",
"     2,41",
"    </a>",
"    ]. The optimal duration of follow-up has not been defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although no universally accepted definition exists for an \"undiagnosed effusion\", the cause of a pleural effusion may not be evident following diagnostic thoracentesis in up to 25 percent of patients. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first step for the clinician is to revisit the patient's history, paying particular attention to drugs, occupational exposures, risk factors for pulmonary embolism and tuberculosis, and comorbid conditions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Uncomplicated parapneumonic effusions and effusions from pulmonary embolism, tuberculous pleurisy, and postcardiac injury syndrome may resolve spontaneously after several weeks, but malignant effusions seldom resolve spontaneously. Benign asbestos effusions, rheumatoid pleurisy, radiation pleuritis, yellow nail syndrome, and trapped lung may persist for months to years. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Time course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A trapped lung occurs when a remote inflammatory process causes a fibrin peel to form on the visceral pleural surface, thereby preventing the lung from expanding to the chest wall. This can be diagnosed by measuring pleural pressure before and after fluid removal during thoracentesis; the decrease in pleural pressure is at least 15 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O per liter of fluid removed. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Trapped lung'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/27/4534?source=see_link\">",
"       \"Measurement of pleural pressure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CT scan of the thorax with contrast should be performed in virtually all patients with an undiagnosed pleural effusion. Additional imaging modalities that may be helpful are CT pulmonary angiogram and positron emission tomography",
"      <span class=\"nowrap\">",
"       (PET)/CT",
"      </span>",
"      scans. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The decision whether to pursue more invasive procedures or simply observe the patient with an undiagnosed pleural effusion requires clinical judgment that is guided by the patient's presentation. As an example, the patient who is over 60 years of age, with an abnormal CT of the pleura, is more likely to have a malignancy as the cause of an undiagnosed exudate and needs further diagnostic evaluation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Closed pleural biopsy is most useful when the pleural abnormality is diffuse as in tuberculous pleurisy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Closed pleural biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CT guided cutting needle biopsy is useful when a pleural based soft tissue abnormality is identified by CT scan. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'CT guided cutting needle biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thoracoscopic biopsy is helpful for malignant effusions, because of the patchy distribution on the pleural surface, and for tuberculous effusions in the setting of a negative closed biopsy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Thoracoscopic pleural biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tuberculous pleurisy can affect any age group and should not be overlooked. Clues to the diagnosis include risk factors for TB exposure and a lymphocytic effusion, especially when pleural adenosine deaminase and interferon-gamma are elevated. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Tuberculous pleurisy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/1\">",
"      Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987; 91:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/2\">",
"      Venekamp LN, Velkeniers B, Noppen M. Does 'idiopathic pleuritis' exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy. Respiration 2005; 72:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/3\">",
"      Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med 2004; 25:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/4\">",
"      Abramov Y, Elchalal U, Schenker JG. Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 1999; 71:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/5\">",
"      Robinson BW, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax 1981; 36:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/6\">",
"      Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest 2004; 125:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/7\">",
"      Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. Chest 2008; 134:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/8\">",
"      Nordkild P, Kromann-Andersen H, Struve-Christensen E. Yellow nail syndrome--the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report. Acta Med Scand 1986; 219:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/9\">",
"      Huggins JT, Sahn SA, Heidecker J, et al. Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest 2007; 131:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/10\">",
"      Porcel JM, Chorda J, Cao G, et al. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/11\">",
"      Long AC, O'Neal HR Jr, Peng S, et al. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. Chest 2010; 137:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/12\">",
"      Hooper, CE, Lee, YCG, Maskell, NA, et al. Investigation of a unilateral pleural effusion in adults: the British Thoracic Society Guidelines. Thorax 2010; 76 (Suppl2):In press.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/13\">",
"      Romero-Candeira S, Fern&aacute;ndez C, Mart&iacute;n C, et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/14\">",
"      STEAD WW, EICHENHOLZ A, STAUSS HK. Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Tuberc 1955; 71:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/15\">",
"      Wrightson JM, Stanton AE, Maskell NA, et al. Pseudochylothorax without pleural thickening: time to reconsider pathogenesis? Chest 2009; 136:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/16\">",
"      Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006; 34:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/17\">",
"      Hooper CE, Lee YC, Maskell NA. Interferon-gamma release assays for the diagnosis of TB pleural effusions: hype or real hope? Curr Opin Pulm Med 2009; 15:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/18\">",
"      Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/19\">",
"      Feinsilver SH, Barrows AA, Braman SS. Fiberoptic bronchoscopy and pleural effusion of unknown origin. Chest 1986; 90:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/20\">",
"      Poe RH, Levy PC, Israel RH, et al. Use of fiberoptic bronchoscopy in the diagnosis of bronchogenic carcinoma. A study in patients with idiopathic pleural effusions. Chest 1994; 105:1663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/21\">",
"      Chang SC, Perng RP. The role of fiberoptic bronchoscopy in evaluating the causes of pleural effusions. Arch Intern Med 1989; 149:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/22\">",
"      Yilmaz U, Polat G, Sahin N, et al. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis 2005; 63:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/23\">",
"      Porcel JM, Madro&ntilde;ero AB, Pardina M, et al. Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients. Respirology 2007; 12:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/24\">",
"      Toaff JS, Metser U, Gottfried M, et al. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography. Invest Radiol 2005; 40:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/25\">",
"      Orki A, Akin O, Tasci AE, et al. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases. Thorac Cardiovasc Surg 2009; 57:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/26\">",
"      Koegelenberg CF, Bolliger CT, Theron J, et al. Direct comparison of the diagnostic yield of ultrasound-assisted Abrams and Tru-Cut needle biopsies for pleural tuberculosis. Thorax 2010; 65:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/27\">",
"      Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/28\">",
"      Metintas M, Ak G, Dundar E, et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest 2010; 137:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/29\">",
"      Ryan CJ, Rodgers RF, Unni KK, Hepper NG. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 1981; 56:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/30\">",
"      Chakrabarti B, Ryland I, Sheard J, et al. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest 2006; 129:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/31\">",
"      Kirsch CM, Kroe DM, Azzi RL, et al. The optimal number of pleural biopsy specimens for a diagnosis of tuberculous pleurisy. Chest 1997; 112:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/32\">",
"      Diacon AH, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003; 22:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/33\">",
"      Benamore RE, Scott K, Richards CJ, Entwisle JJ. Image-guided pleural biopsy: diagnostic yield and complications. Clin Radiol 2006; 61:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/34\">",
"      Rahman, NM, Ali, NJ, Brown, G, et al. Local anaesthetic thoracoscopy: British Thoracic Society plerual disease guidelines 2010. Thorax 2010; 65 (Suppl 2).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/35\">",
"      McLean AN, Bicknell SR, McAlpine LG, Peacock AJ. Investigation of pleural effusion: an evaluation of the new Olympus LTF semiflexible thoracofiberscope and comparison with Abram's needle biopsy. Chest 1998; 114:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/36\">",
"      Davies HE, Nicholson JE, Rahman NM, et al. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010; 38:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/37\">",
"      ROPER WH, WARING JJ. Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc 1955; 71:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/38\">",
"      Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/39\">",
"      Poe RH, Israel RH, Utell MJ, et al. Sensitivity, specificity, and predictive values of closed pleural biopsy. Arch Intern Med 1984; 144:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/40\">",
"      Leslie WK, Kinasewitz GT. Clinical characteristics of the patient with nonspecific pleuritis. Chest 1988; 94:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2632/abstract/41\">",
"      Alem&aacute;n C, Sanchez L, Alegre J, et al. Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures. QJM 2007; 100:351.",
"     </a>",
"    </li>",
"    <li>",
"     Maskell, NA. Undiagnosed pleural effusions. In: Textbook of Pleural Diseases, 2nd, Light, RW, Lee, YCG (Eds), Arnold Press, London 2008. p.491.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6707 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-78.134.254.52-42756325B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2632=[""].join("\n");
var outline_f2_36_2632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TIME COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      REANALYSIS OF PLEURAL FLUID",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TRAPPED LUNG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pleural pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pleural biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Closed pleural biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - CT guided cutting needle biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Thoracoscopic pleural biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TUBERCULOUS PLEURISY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6707\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6707|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/9/38045\" title=\"table 1\">",
"      Exudative pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/49/39708\" title=\"table 2\">",
"      Transudative pleural effusions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=related_link\">",
"      An overview of amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41414?source=related_link\">",
"      An overview of medical thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/62/4072?source=related_link\">",
"      Diagnosis and management of pleural causes of unexpandable lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12663?source=related_link\">",
"      Diagnostic thoracentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28168?source=related_link\">",
"      Drug-induced lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30263?source=related_link\">",
"      Hepatic hydrothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=related_link\">",
"      Imaging of pleural effusions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31382?source=related_link\">",
"      Imaging of pleural plaques, thickening, and tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/59/42933?source=related_link\">",
"      Indications for diagnostic thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=related_link\">",
"      Management of malignant pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/27/4534?source=related_link\">",
"      Measurement of pleural pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=related_link\">",
"      Mechanisms of pleural liquid accumulation in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9735?source=related_link\">",
"      Mechanisms of pleural liquid turnover in the normal state",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=related_link\">",
"      Parapneumonic effusion and empyema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16728?source=related_link\">",
"      Pleural effusions following cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22261?source=related_link\">",
"      Tuberculous pleural effusions in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=related_link\">",
"      Tuberculous pleural effusions in HIV-negative patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_36_2633="Tuberculous pericarditis";
var content_f2_36_2633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tuberculous pericarditis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2633/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2633/contributors\">",
"     Jason Stout, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2633/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2633/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2633/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2633/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/36/2633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous pericarditis is an important complication of tuberculosis (TB); the diagnosis can be difficult to establish and is often delayed or missed, resulting in late complications such as constrictive pericarditis and increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/1\">",
"     1",
"    </a>",
"    ]. Options for management of advanced disease are limited.",
"   </p>",
"   <p>",
"    Issues related to evaluation and management of tuberculous pericarditis will be reviewed here. General issues related to diagnosis and management of TB are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous pericarditis occurs in approximately 1 to 2 percent of patients with pulmonary tuberculosis (TB) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/2\">",
"     2",
"    </a>",
"    ]. In one series of 294 immunocompetent patients in Spain with acute pericarditis (in whom the cause was not apparent at initial evaluation), tuberculous pericarditis was diagnosed in 13 patients (4 percent of cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3\">",
"     3",
"    </a>",
"    ]. Cardiac tamponade was observed in five patients and constrictive pericarditis developed in six patients.",
"   </p>",
"   <p>",
"    In developing countries with a high prevalence of HIV there has been a dramatic increase in tuberculous pericarditis. In one 1994 series of Tanzanian patients with large pericardial effusions, for example, all of the HIV-infected patients were found to have tuberculous pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of tuberculous pericarditis in the United States has declined with the concomitant decline in prevalence of TB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. However, in areas of the United States with large immigrant populations from tuberculosis-endemic countries, extrapulmonary TB, including tuberculous pericarditis, is still seen with some frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericardial infection with M. tuberculosis may occur via extension of infection from the lung or tracheobronchial tree, adjacent lymph nodes, spine, sternum, or via miliary spread. In many patients tuberculous pericarditis represents reactivation disease and the primary focus of infection may be inapparent.",
"   </p>",
"   <p>",
"    Four pathological stages of tuberculous pericarditis have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fibrinous exudation with polymorphonuclear leukocytosis, abundant mycobacteria, and early granuloma formation with loose organization of macrophages and T cells.",
"     </li>",
"     <li>",
"      Serosanguineous effusion with lymphocytic exudate and high protein concentration; tubercle bacilli present in low concentrations.",
"     </li>",
"     <li>",
"      Absorption of effusion with granulomatous caseation and pericardial thickening with subsequent fibrosis.",
"     </li>",
"     <li>",
"      Constrictive scarring; fibrosing visceral and parietal pericardium contracts on the cardiac chambers and may become calcified, leading to constrictive pericarditis which impedes diastolic filling.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Tuberculous pericarditis may progress from one phase to the next, or any one or series of phases may be present without the others. Rarely, the initial phase is identified by biopsy or autopsy as isolated granulomas in the pericardium. In general, the earliest recognizable phase of pericardial infection is the second phase consisting of lymphocytic effusion; the inflammatory process likely reflects a hypersensitivity reaction to tuberculoprotein. The diagnostic yield of pericardial fluid and tissue for acid fast smear and culture is generally highest in the effusive stage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In the absence of treatment, resorption of the effusion with resolution of symptoms occurs over two to four weeks in approximately 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/15\">",
"     15",
"    </a>",
"    ]. Subsequently constriction may or may not occur; the course of disease is variable.",
"   </p>",
"   <p>",
"    Effusive constrictive pericarditis may develop in some patients. This is characterized by concurrent pericardial effusion and pericardial constriction; diastolic pressure persists after removal of pericardial fluid because of persistent constriction. The mechanism consists of visceral pericardial thickening (due in part to healing with fibrosis and calcification), which leads to constriction, and the pressure of pericardial fluid may lead to cardiac tamponade. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=see_link\">",
"     \"Differentiating constrictive pericarditis and restrictive cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2540790\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of tuberculous pericarditis can be nonspecific; fever, weight loss, and night sweats generally precede cardiopulmonary complaints [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/1\">",
"     1",
"    </a>",
"    ]. The nature of symptoms depends upon the stage of infection, degree of extrapericardial tuberculous disease, and degree of pericardial involvement.",
"   </p>",
"   <p>",
"    Patients with tuberculous pericarditis generally present with clinical findings typical of pericarditis or cardiac tamponade. In most cases tuberculous pericarditis is insidious; the onset is acute in up to 25 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/11\">",
"     11",
"    </a>",
"    ]. In one series, the following frequency of symptoms was noted [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cough &mdash; 94 percent",
"     </li>",
"     <li>",
"      Dyspnea &mdash; 88 percent",
"     </li>",
"     <li>",
"      Chest pain (often pleuritic) &mdash;76 percent",
"     </li>",
"     <li>",
"      Night sweats &mdash; 56 percent",
"     </li>",
"     <li>",
"      Orthopnea &mdash; 53 percent",
"     </li>",
"     <li>",
"      Weight loss &mdash; 48 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the frequency of these symptoms is variable. In another report including 41 patients, only 40 to 50 percent had cough, dyspnea, or chest pain, while 70 percent had fever [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/17\">",
"     17",
"    </a>",
"    ]. Right upper abdominal pain due to liver congestion has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A minority of patients present in the late stages of illness with findings typical of constrictive pericarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=see_link\">",
"     \"Differentiating constrictive pericarditis and restrictive cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical findings usually observed with tuberculous pericarditis include fever, tachycardia, increased jugular venous pressure, hepatomegaly, ascites, and peripheral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/16\">",
"     16",
"    </a>",
"    ]. A pericardial friction rub and distant heart sounds are often observed. Cardiac tamponade was present in 10 percent of patients with tuberculous pericardial effusion in a study conducted in South Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/19\">",
"     19",
"    </a>",
"    ]. In advanced disease, signs of heart failure may be observed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/20\">",
"     20",
"    </a>",
"    ]. However, these findings do not distinguish tuberculous pericarditis from other causes (infectious and noninfectious) of pericarditis. (See",
"    <a class=\"local\" href=\"#H2540747\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Potential complications of tuberculous pericarditis include constrictive pericarditis, effusive pericarditis, and cardiac tamponade. The physiology of the various pericardial compressive syndromes is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4025?source=see_link\">",
"     \"Diagnosis and treatment of pericardial effusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Constrictive pericarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constrictive pericarditis occurs in 30 to 60 percent of patients, despite prompt antituberculous therapy and use of corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients with HIV infection may be less likely to develop constriction in the setting of tuberculous pericarditis than HIV-negative individuals; further study is needed to clarify this potential finding [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physical examination may be notable for Kussmaul's sign (lack of an inspiratory decline in jugular venous pressure), elevated and distended jugular veins with a prominent Y descent (the second inward deflection of the internal jugular pulse due to diastolic inflow of blood into the right ventricle), and a pericardial knock (rare). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H10#H10\">",
"     \"Constrictive pericarditis\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulsus paradoxus (an decrease in systolic blood pressure by &gt;10 mmHg on inspiration) is a sign of tamponade and does not indicate constrictive physiology, since in the setting of constriction the inspiratory decline in pressure is not transmitted to the right heart chambers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11158?source=see_link\">",
"     \"Pulsus paradoxus in pericardial disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Effusive constrictive pericarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effusive constrictive pericarditis is characterized by pericardial constriction and pericardial effusion and has been studied most in Southern Africa. The constrictive hemodynamics persist even after removal of the effusion. Effusive constrictive pericarditis can be difficult to distinguish from constrictive pericarditis; clinical clues include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pulsus paradoxus",
"     </li>",
"     <li>",
"      Absence of a pericardial knock",
"     </li>",
"     <li>",
"      A less dominant Y descent than expected",
"     </li>",
"     <li>",
"      Frequent absence of Kussmaul's sign",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of effusive constrictive pericarditis often becomes apparent during pericardiocentesis in patients initially thought to have tamponade. Despite lowering the pericardial pressure to normal, the elevated right atrial pressure persists in associated with the development of Y dominance and impaired respiratory variation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=see_link\">",
"     \"Differentiating constrictive pericarditis and restrictive cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H23#H23\">",
"     \"Constrictive pericarditis\", section on 'Effusive constrictive pericarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Cardiac tamponade",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination in cardiac tamponade may demonstrate hypotension with a narrow pulse pressure, reflecting the limited stroke volume. Other findings include sinus tachycardia (permitting at least partial maintenance of cardiac output), elevated jugular venous pressure, pulsus paradoxus, and ascites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link&amp;anchor=H13#H13\">",
"     \"Cardiac tamponade\", section on 'Physical findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients presenting with ascites in the absence of other findings may be erroneously thought to have cirrhosis. The main clue to the diagnosis of tamponade is elevation of jugular venous pressure, which is not seen in cirrhosis unless there is tense ascites (which may increase venous pressure slightly) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4888454\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2584395\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous pericarditis should be considered in the evaluation of patients with pericarditis who do not have a self-limited course, in the setting of risk factors for tuberculosis (TB) exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3\">",
"     3",
"    </a>",
"    ]. The diagnosis is established by detection of tubercle bacilli in smear or culture of pericardial fluid,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    detection of tubercle bacilli or caseating granulomata on histological examination of the pericardium [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/12\">",
"     12",
"    </a>",
"    ]. Tuberculous pericarditis is considered likely in the setting of pericarditis with tuberculosis demonstrated elsewhere in the body, lymphocytic pericardial exudate with elevated adenosine deaminase level,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinical response to antituberculous therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3617535\">",
"    <span class=\"h2\">",
"     Initial evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial evaluation consists of chest radiography, echocardiography, and evaluation of sputum for AFB smear and culture. Additional studies may include computed tomography (CT)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    magnetic resonance imaging (MRI) of the chest in areas where available. A",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    interferon gamma release assay may or may not be helpful. In many cases pericardiocentesis is also warranted. (See",
"    <a class=\"local\" href=\"#H4888789\">",
"     'Pericardiocentesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The likelihood of detecting evidence of pulmonary tuberculosis on chest x-ray in the setting of tuberculous pericarditis is variable and ranges from 32 to 72 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3,16,19,24\">",
"     3,16,19,24",
"    </a>",
"    ]. Cardiac findings on chest x-ray in the setting of tuberculous pericarditis include enlarged cardiac shadow in more than 90 percent of cases; in the setting of chronic pericarditis, pericardial calcification may be observed. Pleural effusions may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3,24\">",
"     3,24",
"    </a>",
"    ]. Interpretation of chest radiography in the setting of tuberculosis is discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Chest radiography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Echocardiography is an accurate and noninvasive tool for establishing the presence of a pericardial effusion and to detect signs of tamponade (",
"    <a class=\"graphic graphic_movie graphicRef51184 \" href=\"UTD.htm?23/39/24190\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef64027 \" href=\"UTD.htm?29/24/30094\">",
"     movie 2",
"    </a>",
"    ). The role of echocardiography in evaluation of pericardial effusion is discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4025?source=see_link\">",
"     \"Diagnosis and treatment of pericardial effusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A thorough evaluation for tuberculosis should also include evaluation for presence of acid-fast bacilli in the sputum smear and culture; positive results have been observed in 10 to 55 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3,25\">",
"     3,25",
"    </a>",
"    ]. Alternative approaches include AFB smear and culture of gastric washings (in children) and urine [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    MRI of the chest can demonstrate pericardial effusion, pericardial thickening, and lymphadenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/26\">",
"     26",
"    </a>",
"    ]. Characteristic lymph node involvement is mediastinal and tracheobronchial (with hilar sparing) and &gt;10 mm with hypodense centers and matting.",
"   </p>",
"   <p>",
"    The electrocardiogram is abnormal in virtually all cases of tuberculous pericardial effusion, usually in the form of nonspecific ST-T wave changes. Electrocardiographic findings seen in pericarditis and pericardial effusion are discussed in detail separately (",
"    <a class=\"graphic graphic_waveform graphicRef72525 \" href=\"UTD.htm?42/27/43450\">",
"     waveform 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/7/23669?source=see_link\">",
"     \"Electrocardiogram in pericarditis and pericardial effusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tuberculin skin tests and interferon gamma release assays are useful for detecting TB infection but do not distinguish between latent TB infection and active TB disease. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    is positive in most immunocompetent patients with tuberculous pericarditis (85 percent of cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/4,27\">",
"     4,27",
"    </a>",
"    ]. In contrast, the tuberculin skin test is often negative in patients with HIV infection and tuberculous pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data on use of interferon gamma release assays in the setting of tuberculous pericarditis are limited, but like the skin test, they do not distinguish between latent TB infection and active TB disease, so are unlikely to be diagnostically helpful in TB-endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4888789\">",
"     'Pericardiocentesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4888789\">",
"    <span class=\"h2\">",
"     Pericardiocentesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericardiocentesis is warranted for routine evaluation of suspected tuberculous pericarditis; cardiac tamponade is an absolute indication for pericardiocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/15\">",
"     15",
"    </a>",
"    ]. Open drainage (rather than pericardiocentesis) does not appear to influence need for pericardiectomy or reduce the likelihood of subsequent constriction or death [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/19\">",
"     19",
"    </a>",
"    ]. The diagnostic yield of pericardial fluid is generally highest in the effusive stage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Pathogenesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The technique for pericardiocentesis is described separately. The fluid should be evaluated for cell count, protein concentration, lactate dehydrogenase concentration, acid fast",
"    <span class=\"nowrap\">",
"     smear/culture,",
"    </span>",
"    Gram stain and bacterial culture, adenosine deaminase concentration and cytology. Tuberculous pericardial effusions are typically exudative and characterized by high protein content and increased leukocyte count, with a predominance of lymphocytes and monocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In one study, a pericardial",
"    <span class=\"nowrap\">",
"     lymphocyte/neutrophil",
"    </span>",
"    ratio &ge;1.0 had high sensitivity, specificity, and positive predictive value for diagnosis of tuberculous cause of pericardial effusion (73, 79, and 86 percent respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29\">",
"     29",
"    </a>",
"    ]. The percentage of lymphocytes in the pericardial fluid is characteristically lower in patients with HIV infection than in HIV-negative patients (36 versus 52 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29\">",
"     29",
"    </a>",
"    ]. Light&rsquo;s criteria for exudative pleural effusions may also be used to establish the presence of pericardial exudate [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25159?source=see_link\">",
"     \"Technique of pericardiocentesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acid fast bacilli are seen on smear of pericardial fluid in 40 to 60 percent of patients with tuberculous pericarditis; the yield is increased by culture [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/16,19,29\">",
"     16,19,29",
"    </a>",
"    ]. In one study including 162 patients with tuberculous pericarditis (half of whom also had HIV infection), pericardial fluid cultures were positive in 56 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29\">",
"     29",
"    </a>",
"    ]. In individual patients with tuberculous pericarditis, the diagnostic tools available may be positive singly or in combination.",
"   </p>",
"   <p>",
"    Polymerase chain reaction (PCR) for mycobacterial DNA in pericardial fluid may also be useful for diagnosis of tuberculous pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29,33-35\">",
"     29,33-35",
"    </a>",
"    ]. However, most studies on the validity of PCR in the diagnosis of extrapulmonary tuberculosis have involved relatively small numbers of patients and have been performed in endemic areas; the utility of PCR in nonendemic areas has not been studied extensively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H4856569#H4856569\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Culture'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H4856355#H4856355\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Molecular tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Measurement of pericardial adenosine deaminase (ADA) level can be useful for diagnosis of tuberculous pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29,35\">",
"     29,35",
"    </a>",
"    ]. Different cutoff levels for ADA activity have been suggested as indicative of disease, ranging from 30 to 60",
"    <span class=\"nowrap\">",
"     U/L.",
"    </span>",
"    In one study of 64 patients in South Africa with tuberculous pericarditis, the median ADA level was 72",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    (range 10 to 304",
"    <span class=\"nowrap\">",
"     U/L);",
"    </span>",
"    this level was significantly higher than the ADA levels in patients with other etiologies of pericarditis. Using a cutoff ADA level of 30",
"    <span class=\"nowrap\">",
"     U/L,",
"    </span>",
"    the authors calculated a sensitivity of 94 percent, specificity of 68 percent and positive predictive value of 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/36\">",
"     36",
"    </a>",
"    ]. Another study noted a positive correlation between high pericardial ADA levels and subsequent development of constrictive pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/37\">",
"     37",
"    </a>",
"    ]. Lower ADA levels have been observed in HIV-infected patients with severe CD4 lymphocyte depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/25\">",
"     25",
"    </a>",
"    ]. ADA testing is limited to specialized laboratories and proper interpretation requires consideration of pretest probability for tuberculous pericarditis; in areas where the prevalence of tuberculosis is low, the utility of the pericardial ADA test is correspondingly low.",
"   </p>",
"   <p>",
"    Data on use of interferon-gamma testing for evaluation of pericardial fluid are limited. In one study including 162 patients with tuberculous pericarditis in South Africa, the sensitivity of pericardial interferon-gamma was 73 percent; approximately half of patients had HIV infection, but test results were not affected by HIV status [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/29\">",
"     29",
"    </a>",
"    ]. The mean interferon gamma concentrations in HIV-negative tuberculous effusions, HIV-positive tuberculous effusions, and non-tuberculous effusions were 781, 624, and 27",
"    <span class=\"nowrap\">",
"     pg/mL,",
"    </span>",
"    respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2584575\">",
"    <span class=\"h2\">",
"     Pericardial biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis may remain uncertain after evaluation as described in the preceding sections, including evaluation for tubercle bacilli in sputum, pericardial fluid, and other body sites. In such cases, options for next diagnostic steps include right scalene lymph node biopsy (if lymphadenopathy is present)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pericardial biopsy. For patients in areas where TB is endemic for whom clinical suspicion of tuberculous pericarditis is high, pericardial biopsy is not required prior to initiation of empiric antituberculous therapy. In areas where TB is not endemic, a pericardial biopsy is warranted for patients with duration of illness &gt;3 weeks in the absence of definitive diagnosis via the other investigations described above [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3617535\">",
"     'Initial evaluation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4888789\">",
"     'Pericardiocentesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Earlier studies suggested that tuberculous pericarditis was more readily diagnosed from pericardial biopsy than pericardial fluid alone [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/38\">",
"     38",
"    </a>",
"    ]. Subsequently, prospective data has shown that culture of pericardial fluid confirmed the presence of tuberculous more often than pericardial histology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/19\">",
"     19",
"    </a>",
"    ]. Histology appears to be most important for cases in which no pericardial fluid can be obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissues obtained by biopsy should be stained with acid fast reagents and examined for histological evidence of granulomatous inflammation. The sensitivity of pericardial biopsy for diagnosis of tuberculous pericarditis ranges from 10 to 64 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Therefore a normal pericardial biopsy specimen does not exclude tuberculous pericarditis; in some cases examination of the full pericardium is required to establish the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/40\">",
"     40",
"    </a>",
"    ]. The diagnostic yield of pericardial tissue is generally highest in the effusive stage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Pathogenesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2540747\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of tuberculous pericarditis includes pericarditis due to other infectious etiologies (eg, viral, bacterial, fungal pathogens) as well as non-infectious entities including sarcoidosis, malignancy, radiation damage, trauma, and hemopericardium. The clinical approach to these diseases is discussed separately (see related topics).",
"   </p>",
"   <p>",
"    Patients with both tamponade and inflammation have a greater likelihood of tuberculosis infection than patients with either tamponade or inflammation alone [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/41\">",
"     41",
"    </a>",
"    ]. In endemic areas tuberculous pericarditis is an important cause of heart failure; it is less common than rheumatic heart disease but more common than heart failure due to hypertension or cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The differential diagnosis of mediastinal lymphadenopathy includes lymphoma, malignancy, and sarcoidosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antituberculous therapy has been shown to dramatically reduce mortality among patients with tuberculous pericarditis, from 80 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/30\">",
"     30",
"    </a>",
"    ] down to 8 to 17 percent among HIV-negative individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/20,44\">",
"     20,44",
"    </a>",
"    ] and 17 to 34 percent among HIV-infected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/45\">",
"     45",
"    </a>",
"    ]. Antituberculous therapy has also been shown to reduce the likelihood of constrictive pericarditis, from 88 percent down to 10 to 20 percent of treated cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/17,46\">",
"     17,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Antituberculous therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to antituberculous therapy for treatment of tuberculous pericarditis is generally the same as that for pulmonary tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. The drug regimen varies with whether or not the patient has HIV infection or drug-resistant tuberculosis. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link\">",
"     \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients in areas where TB is endemic for whom clinical suspicion of tuberculous pericarditis is high, initiation of empiric antituberculous therapy is appropriate prior to establishing a definitive diagnosis. Among patients for whom diagnosis cannot be established based on bacteriology, histology, or pericardial fluid analysis, clinical response to antituberculous therapy serves as support for a diagnosis of tuberculous pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/12\">",
"     12",
"    </a>",
"    ]. In areas where TB is not endemic, antituberculous therapy should generally not be initiated empirically in the absence of definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Role of corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of corticosteroids in tuberculous pericarditis is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/19,35,45,50-53\">",
"     19,35,45,50-53",
"    </a>",
"    ]. Three clinical trials (with a total of 326 participants) have been performed to assess the effectiveness of adjunctive steroids in management tuberculous effusion; two were performed in the pre-HIV era [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/19,45,53\">",
"     19,45,53",
"    </a>",
"    ]. The available data demonstrate that corticosteroids can shorten the time to resolution of clinical symptoms and decrease reaccumulation of fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/54\">",
"     54",
"    </a>",
"    ]. They also suggest a trend toward reduction in mortality, but none of the results was statistically significant. In addition, corticosteroids do not appear to affect the likelihood of pericardial effusion reaccumulation or progression to constrictive pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Corticosteroids appear to be most useful among patients with constrictive pericarditis. Among 143 patients with tuberculous pericarditis and constrictive physiology in South Africa randomized to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    or placebo in addition to antituberculous therapy during the first 11 weeks of treatment, corticosteroids hastened clinical improvement, reduced the need for pericardiectomy, and reduced mortality, although the findings were not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We are in agreement with the 2003 guidelines issued by the American Thoracic Society, Centers for Disease Control, and Infectious Diseases Society of America which favor use of corticosteroids for treatment of all patients with tuberculous pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/52\">",
"     52",
"    </a>",
"    ]. Use of corticosteroids is likely to be most beneficial for patients with constrictive pericarditis. For adults the regimen is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    60",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    (or the equivalent dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    ) given for four weeks, followed by 30",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for four weeks, 15",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for two weeks, and 5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for one week. Children should be treated with doses proportionate to their weight, beginning with about 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    body weight and decreasing the dose as described for adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pericardiectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericardiectomy is warranted in the setting of persistent constrictive pericarditis despite antituberculous therapy. The timing is controversial, and data are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/5,35\">",
"     5,35",
"    </a>",
"    ]. Some favor pericardiectomy for all patients with constrictive pericarditis once antituberculous therapy has been initiated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/57\">",
"     57",
"    </a>",
"    ], while others favor reserving pericardiectomy for patients that do not respond to antituberculous therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/3,56\">",
"     3,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, pericardiectomy is appropriate for patients with hemodynamics that fail to improve or hemodynamics that deteriorate after four to eight weeks of antituberculous therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2633/abstract/46\">",
"     46",
"    </a>",
"    ]. Earlier intervention is warranted for patients with pericardial calcification, a marker of chronic disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H21#H21\">",
"     \"Constrictive pericarditis\", section on 'Chronic constrictive pericarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/53/12115?source=see_link\">",
"       \"Patient information: Pericarditis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6330849\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tuberculous pericarditis occurs in approximately 1 to 2 percent of patients with pulmonary tuberculosis (TB). Four pathological stages of tuberculous pericarditis have been described: fibrinous exudation, lymphocytic effusion, absorption of effusion with granulomatous caseation, and constrictive scarring. The earliest recognizable phase of pericardial infection is the second phase, and the diagnostic yield of pericardial fluid and tissue for acid fast smear and culture is highest in this stage. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of tuberculous pericarditis can be nonspecific; fever, weight loss, and night sweats generally precede cardiopulmonary complaints and the onset is usually insidious. Symptoms may include cough, dyspnea, chest pain, pleurisy, orthopnea, night sweats, and weight loss. Physical findings may include fever, tachycardia, pleural dullness, increased jugular venous pressure, hepatomegaly, ascites, and peripheral edema. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tuberculous pericarditis should be considered in the evaluation of patients with pericarditis who do not have a self-limited course, in the setting of risk factors for TB exposure. The diagnosis is established by detection of tubercle bacilli in smear or culture of pericardial fluid,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      detection of tubercle bacilli or caseating granulomata on histological examination of the pericardium. Tuberculous pericarditis is considered likely in the setting of pericarditis with tuberculosis demonstrated elsewhere in the body, lymphocytic pericardial exudate with elevated adenosine deaminase level,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      clinical response to antituberculous therapy. (See",
"      <a class=\"local\" href=\"#H2584395\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial diagnostic evaluation consists of chest radiography, echocardiography, and evaluation of sputum for acid fast bacilli smear and culture. Pericardiocentesis is warranted for routine evaluation of suspected tuberculous pericarditis; cardiac tamponade is an absolute indication for pericardiocentesis. (See",
"      <a class=\"local\" href=\"#H3617535\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pericardial fluid should be evaluated for cell count, protein concentration, lactate dehydrogenase concentration, acid fast",
"      <span class=\"nowrap\">",
"       smear/culture,",
"      </span>",
"      Gram stain and bacterial culture, adenosine deaminase concentration, and cytology. Tuberculous pericardial effusions are typically exudative and characterized by high protein content and increased leukocyte count, with a predominance of lymphocytes and monocytes. Light&rsquo;s criteria for exudative pleural effusions may also be used to establish the presence of pericardial exudate. (See",
"      <a class=\"local\" href=\"#H4888789\">",
"       'Pericardiocentesis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"       \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For circumstances in which the diagnosis remains uncertain, options for next diagnostic steps include right scalene lymph node biopsy (if lymphadenopathy is present),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pericardial biopsy. For patients in areas where TB is endemic for whom clinical suspicion of tuberculous pericarditis is high, pericardial biopsy is not required prior to initiation of empiric antituberculous therapy. In areas where TB is not endemic, a pericardial biopsy is warranted for patients with duration of illness &gt;3 weeks in the absence of definitive diagnosis via the other investigations described above. (See",
"      <a class=\"local\" href=\"#H2584575\">",
"       'Pericardial biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to antituberculous therapy for treatment of tuberculous pericarditis is generally the same as that for pulmonary tuberculosis. The drug regimen varies with whether or not the patient has HIV infection or drug-resistant tuberculosis. These issues are discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"       \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"       \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link\">",
"       \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The role of corticosteroids in tuberculous pericarditis is controversial, and data are limited. For patients with constrictive tuberculous pericarditis, we recommend administration of corticosteroids (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ); for patients with tuberculous pericarditis that is not constrictive, we suggest administration of corticosteroids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Dosing is outlined above. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Role of corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H71928312\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to recognize Dr. G. Ralph Corey and Dr. Daniel Sexton for their contributions to previous versions of this topic.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/1\">",
"      Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/2\">",
"      Larrieu AJ, Tyers GF, Williams EH, Derrick JR. Recent experience with tuberculous pericarditis. Ann Thorac Surg 1980; 29:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/3\">",
"      Sagrist&agrave;-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol 1988; 11:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/4\">",
"      Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung Dis 1994; 75:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/5\">",
"      McCaughan BC, Schaff HV, Piehler JM, et al. Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg 1985; 89:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/6\">",
"      Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J 1987; 113:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/7\">",
"      ROBERTSON R, ARNOLD CR. Constrictive pericarditis with particular reference to etiology. Circulation 1962; 26:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/8\">",
"      Trautner BW, Darouiche RO. Tuberculous pericarditis: optimal diagnosis and management. Clin Infect Dis 2001; 33:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/9\">",
"      Fiske CT, Griffin MR, Erin H, et al. Black race, sex, and extrapulmonary tuberculosis risk: an observational study. BMC Infect Dis 2010; 10:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/10\">",
"      Kipp AM, Stout JE, Hamilton CD, Van Rie A. Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993 - 2006. BMC Public Health 2008; 8:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/11\">",
"      Ortbals DW, Avioli LV. Tuberculous pericarditis. Arch Intern Med 1979; 139:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/12\">",
"      Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005; 112:3608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/13\">",
"      Strang G, Latouf S, Commerford P, et al. Bedside culture to confirm tuberculous pericarditis. Lancet 1991; 338:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/14\">",
"      BARR JF. The use of pericardial biopsy in establishing etiologic diagnosis in acute pericarditis. AMA Arch Intern Med 1955; 96:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/15\">",
"      Permanyer-Miralda G, Sagrist&aacute;-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/16\">",
"      Fowler NO, Manitsas GT. Infectious pericarditis. Prog Cardiovasc Dis 1973; 16:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/17\">",
"      Gooi HC, Smith JM. Tuberculous pericarditis in Birmingham. Thorax 1978; 33:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/18\">",
"      HAGEMAN JH, D ESOPO ND, GLENN WW. TUBERCULOSIS OF THE PERICARDIUM. A LONG-TERM ANALYSIS OF FORTY-FOUR PROVED CASES. N Engl J Med 1964; 270:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/19\">",
"      Strang JI, Kakaza HH, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988; 2:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/20\">",
"      Desai HN. Tuberculous pericarditis. A review of 100 cases. S Afr Med J 1979; 55:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/21\">",
"      Ntsekhe M, Wiysonge CS, Gumedze F, et al. HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study. PLoS One 2008; 3:e2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/22\">",
"      Hancock EW. On the elastic and rigid forms of constrictive pericarditis. Am Heart J 1980; 100:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/23\">",
"      Guazzi M, Polese A, Magrini F, et al. Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med 1975; 59:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/24\">",
"      Reuter H, Burgess LJ, Doubell AF. Role of chest radiography in diagnosing patients with tuberculous pericarditis. Cardiovasc J S Afr 2005; 16:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/25\">",
"      Reuter H, Burgess LJ, Carstens ME, Doubell AF. Adenosine deaminase activity--more than a diagnostic tool in tuberculous pericarditis. Cardiovasc J S Afr 2005; 16:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/26\">",
"      Cherian G. Diagnosis of tuberculous aetiology in pericardial effusions. Postgrad Med J 2004; 80:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/27\">",
"      Rooney JJ, Crocco JA, Lyons HA. Tuberculous pericarditis. Ann Intern Med 1970; 72:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/28\">",
"      Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/29\">",
"      Reuter H, Burgess L, van Vuuren W, Doubell A. Diagnosing tuberculous pericarditis. QJM 2006; 99:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/30\">",
"      Harvey AM, Whitehill MR. Tuberculous pericarditis. Medicine 1937; 16:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/31\">",
"      Light RW. Pleural effusions. Med Clin North Am 1977; 61:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/32\">",
"      Burgess LJ, Reuter H, Carstens ME, et al. Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 2002; 6:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/33\">",
"      Rana BS, Jones RA, Simpson IA. Recurrent pericardial effusion: the value of polymerase chain reaction in the diagnosis of tuberculosis. Heart 1999; 82:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/34\">",
"      Lee JH, Lee CW, Lee SG, et al. Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis. Am J Med 2002; 113:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/35\">",
"      Maisch B, Seferovi�� PM, Risti�� AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/36\">",
"      Burgess LJ, Reuter H, Carstens ME, et al. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest 2002; 122:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/37\">",
"      Komsuo��lu B, G&ouml;ldel&iuml; O, Kulan K, Komsuo��lu SS. The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. Eur Heart J 1995; 16:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/38\">",
"      SCHEPERS GW. Tuberculous pericarditis. Am J Cardiol 1962; 9:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/39\">",
"      Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med 1993; 95:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/40\">",
"      Cheitlin MD, Serfas LJ, Sbar SS, Glasser SP. Tuberculous pericarditis: is limited pericardial biopsy sufficient for diagnosis? Report of two cases. Am Rev Respir Dis 1968; 98:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/41\">",
"      Sagrist&agrave;-Sauleda J, Merc&eacute; J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med 2000; 109:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/42\">",
"      Strang JI. Tuberculous pericarditis in Transkei. Clin Cardiol 1984; 7:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/43\">",
"      Hakim JG, Manyemba J. Cardiac disease distribution among patients referred for echocardiography in Harare, Zimbabwe. Cent Afr J Med 1998; 44:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/44\">",
"      Bhan GL. Tuberculous pericarditis. J Infect 1980; 2:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/45\">",
"      Hakim JG, Ternouth I, Mushangi E, et al. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000; 84:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/46\">",
"      Long R, Younes M, Patton N, Hershfield E. Tuberculous pericarditis: long-term outcome in patients who received medical therapy alone. Am Heart J 1989; 117:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/47\">",
"      Cohn DL, Catlin BJ, Peterson KL, et al. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990; 112:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/48\">",
"      Combs DL, O'Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med 1990; 112:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/49\">",
"      Soler-Soler J, Sagrist&agrave;-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart 2001; 86:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/50\">",
"      Strang JI, Nunn AJ, Johnson DA, et al. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM 2004; 97:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/51\">",
"      Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002; :CD000526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/52\">",
"      American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/53\">",
"      SCHRIRE V. Experience with pericarditis at Groote Schuur Hospital, Cape Town: an analysis of one hundred and sixty cases studied over a six-year period. S Afr Med J 1959; 33:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/54\">",
"      Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997; 25:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/55\">",
"      Ntsekhe M, Wiysonge C, Volmink JA, et al. Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. QJM 2003; 96:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/56\">",
"      Strang JI, Kakaza HH, Gibson DG, et al. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 1987; 2:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2633/abstract/57\">",
"      Carson TJ, Murray GF, Wilcox BR, Starek PJ. The role of surgery in tuberculous pericarditis. Ann Thorac Surg 1974; 17:163.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8002 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.65.114.212-1237D62C13-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2633=[""].join("\n");
var outline_f2_36_2633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6330849\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2540790\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Effusive constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4888454\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2584395\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3617535\">",
"      Initial evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4888789\">",
"      Pericardiocentesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2584575\">",
"      Pericardial biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2540747\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Antituberculous therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Role of corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pericardiectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6330849\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71928312\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8002\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8002|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?23/39/24190\" title=\"movie 1\">",
"      Pericardial effusion without tamponade subcostal view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?29/24/30094\" title=\"movie 2\">",
"      Pericardial effusion with tamponade subcostal view",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8002|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/27/43450\" title=\"waveform 1\">",
"      ECG in electrical alternans",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4025?source=related_link\">",
"      Diagnosis and treatment of pericardial effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=related_link\">",
"      Diagnosis, treatment, and prevention of drug-resistant tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=related_link\">",
"      Differentiating constrictive pericarditis and restrictive cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/7/23669?source=related_link\">",
"      Electrocardiogram in pericarditis and pericardial effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/53/12115?source=related_link\">",
"      Patient information: Pericarditis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11158?source=related_link\">",
"      Pulsus paradoxus in pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25159?source=related_link\">",
"      Technique of pericardiocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=related_link\">",
"      Treatment of pulmonary tuberculosis in the HIV-infected patient",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_36_2634="Association between Helicobacter pylori infection and gastrointestinal malignancy";
var content_f2_36_2634=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Association between Helicobacter pylori infection and gastrointestinal malignancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2634/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2634/contributors\">",
"     Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2634/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2634/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/36/2634/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/36/2634/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/36/2634/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the discovery of",
"    <em>",
"     Helicobacter pylori",
"    </em>",
"    (",
"    <em>",
"     H. pylori",
"    </em>",
"    ) in the 1980s, much has been learned about this gram-negative spiral bacteria and its associated disease states. In 1994, the National Institutes of Health (NIH) Consensus Conference recognized",
"    <em>",
"     H. pylori",
"    </em>",
"    as a cause of gastric and duodenal ulcers. Later that year, the International Agency for Research on Cancer (IARC) declared",
"    <em>",
"     H. pylori",
"    </em>",
"    to be a group I human carcinogen for gastric adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/1\">",
"     1",
"    </a>",
"    ]. There is also evidence that",
"    <em>",
"     H. pylori",
"    </em>",
"    infection is a risk factor for gastric mucosa-associated lymphomas (MALT lymphomas). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=see_link\">",
"     \"Clinical presentation and diagnosis of primary gastrointestinal lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these clear associations, there is marked individual variability in the outcomes of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection, with most patients having a nonneoplastic rather than neoplastic process.",
"    <em>",
"     H. pylori",
"    </em>",
"    infection is associated with a complex interaction between genetic, environmental, and bacterial factors, which potentially explains the different outcomes possible following infection. Until these factors are better defined and their interactions better understood, practitioners should limit testing for and treating",
"    <em>",
"     H. pylori",
"    </em>",
"    to those situations where there is evidence to support a clinical benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GASTRIC CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric cancer is one of the most common causes of cancer-related death in the world [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4661?source=see_link\">",
"     \"Epidemiology of gastric cancer\"",
"    </a>",
"    .) Gastric cancers can be categorized by site of occurrence: gastroesophageal junction, proximal stomach, and distal stomach (body and antrum). In the 1930s in the United States, distal cancers were the most common. Over the subsequent 70 years, the incidence of gastric cancer has fallen primarily due to a reduction in distal cancers. In comparison, an increase in the incidence of gastroesophageal junction and proximal cancers has been noted during the past several decades [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. These observations suggest that gastroesophageal and proximal gastric cancers share a common pathogenesis, which is distinct from that of distal cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adenocarcinomas, which accounts for more than 90 percent of tumors arising in the stomach, are of two distinct morphologic types: intestinal-type and diffuse. A sequence of steps with phenotypic changes in the gastric mucosa has been hypothesized as a model for carcinogenesis of intestinal type adenocarcinomas: superficial gastritis; chronic atrophic gastritis; intestinal metaplasia (",
"    <a class=\"graphic graphic_picture graphicRef64199 \" href=\"UTD.htm?17/24/17802\">",
"     picture 1",
"    </a>",
"    ); dysplasia; and finally carcinoma (",
"    <a class=\"graphic graphic_algorithm graphicRef73741 \" href=\"UTD.htm?10/39/10878\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/6\">",
"     6",
"    </a>",
"    ]. No similar sequence has been described for the diffuse type. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=see_link\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <em>",
"     H. pylori",
"    </em>",
"    can cause chronic active gastritis and atrophic gastritis, early steps in the carcinogenesis sequence [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In animal models,",
"    <em>",
"     H. pylori",
"    </em>",
"    infection has induced gastric adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/9\">",
"     9",
"    </a>",
"    ]. Furthermore, a number of studies in humans have demonstrated a clear association between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and gastric adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. The link has been demonstrated in both the intestinal and diffuse subtypes of gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/10,13\">",
"     10,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and gastric carcinogenesis in humans can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       H. pylori",
"      </em>",
"      has been identified histologically in the uninvolved mucosa from stomachs harboring cancers or precancerous changes (eg, atrophic gastritis with or without accompanying intestinal metaplasia) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/14,15\">",
"       14,15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Epidemiologic studies demonstrate a strong correlation between",
"      <em>",
"       H. pylori",
"      </em>",
"      seropositivity and gastric cancer. As an example, the EUROGAST study of 17 populations from 13 different countries (11 European countries, the United States, and Japan) found a sixfold increased risk of gastric cancer in",
"      <em>",
"       H. pylori",
"      </em>",
"      -infected populations compared with uninfected populations [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/16\">",
"       16",
"      </a>",
"      ]. Similar findings have been noted in nested-case control studies in which the stored serum of patients with known gastric adenocarcinoma and that of matched controls were tested for",
"      <em>",
"       H. pylori",
"      </em>",
"      IgG antibody.",
"      <em>",
"       H. pylori",
"      </em>",
"      infection was associated with odds ratios ranging from 2.8 to 49 and attributable risks of 46 to 63 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/12,17-20\">",
"       12,17-20",
"      </a>",
"      ]. In a nested case-control study of Japanese Americans living in Hawaii, for example,",
"      <em>",
"       H. pylori",
"      </em>",
"      seropositivity was present in 94 percent of patients with gastric cancer compared with 76 percent of matched controls; the odds ratio was 6.0 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two meta-analysis of cohort and case-control studies examining the relationship between",
"      <em>",
"       H. pylori",
"      </em>",
"      seropositivity and gastric cancer found that",
"      <em>",
"       H. pylori",
"      </em>",
"      infection was associated with a twofold increased risk for developing gastric adenocarcinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. The relative risk for gastric cancer was greatest for younger patients (9.29 at age less than 29) in whom the absolute risk is still quite low [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One of the largest prospective studies addressing",
"    <em>",
"     H. pylori",
"    </em>",
"    and cancer risk included 1526 Japanese patients of whom 1246 had",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/21\">",
"     21",
"    </a>",
"    ]. Patients underwent endoscopy with biopsy at enrollment and then at one and three years. During a mean follow-up of 7.8 years, 36 patients developed gastric cancer (2.9 percent), all of whom were",
"    <em>",
"     H. pylori",
"    </em>",
"    infected. No uninfected patient developed cancer.",
"   </p>",
"   <p>",
"    The IARC estimates that 36 and 47 percent of all gastric cancers in developed and developing countries, respectively, are solely attributable to",
"    <em>",
"     H. pylori",
"    </em>",
"    infection. This accounts for almost 350,000 gastric cancers annually worldwide.",
"   </p>",
"   <p>",
"    Despite the clear association between",
"    <em>",
"     H. pylori",
"    </em>",
"    and gastric adenocarcinomas, only a minority of infected individuals will develop gastric cancer. It is thought that modulation of the effects of infection by external, mostly environmental factors (and possibly strain differences in",
"    <em>",
"     H. pylori",
"    </em>",
"    , see below) influence whether infection results in a neoplastic or nonneoplastic process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Role of H. pylori in carcinogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several hypotheses have been proposed to explain the role of",
"    <em>",
"     H. pylori",
"    </em>",
"    in carcinogenesis, although the exact mechanism is incompletely understood [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/22\">",
"     22",
"    </a>",
"    ]. A potentially important observation is that the source of gastric cancer may not be from gastric epithelial cells themselves but rather from bone-marrow derived cells that differentiate into gastric epithelial cells in the presence of",
"    <em>",
"     H. pylori",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/23\">",
"     23",
"    </a>",
"    ]. If this observation is confirmed, it would have significant implications for the treatment of",
"    <em>",
"     H. pylori",
"    </em>",
"    -associated gastric cancer as well as other epithelial cancers associated with chronic inflammation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=see_link&amp;anchor=H13#H13\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\", section on 'Migrating bone marrow derived cells'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Neutrophil activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;One hypothesis has been demonstrated in vitro.",
"    <span class=\"nowrap\">",
"     CD11a/CD18-",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     CD11b/CD18-",
"    </span>",
"    neutrophils, induced by",
"    <em>",
"     H. pylori",
"    </em>",
"    infection, interact with intercellular adhesion molecule-1 (ICAM-1), resulting in the migration of neutrophils to the site of infection and adhesion to the surface epithelium. The recruited neutrophils then produce inducible nitric oxide synthase and release nitric oxide and reactive oxygen metabolites, such as superoxide and hydroxyl ions, which in turn damage DNA. This is followed by mutation and malignant transformation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\", section on 'Models of molecular pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Hypochlorhydria and ascorbic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another hypothesis involves a role for hypochlorhydria and ascorbic acid (",
"    <a class=\"graphic graphic_algorithm graphicRef73741 \" href=\"UTD.htm?10/39/10878\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/6\">",
"     6",
"    </a>",
"    ]. In the sequence of carcinogenesis from atrophic gastritis to metaplasia, loss of the acid-secreting parietal cells results in an elevated gastric pH. Nitrate-reducing bacteria proliferate in the stomach and, at the high pH, nitrite is formed, which can interact with other nitrogen-containing compounds and with carcinogens. Ascorbic acid may block this nitrosation reaction by scavenging nitrates and free radicals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following observations suggest a role for the relative lack of ascorbic acid in the pathogenesis of gastric cancer:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The level of ascorbic acid in gastric juice is markedly reduced in the setting of chronic gastritis, elevated gastric pH and",
"      <em>",
"       H. pylori",
"      </em>",
"      infection; this may be due to impaired secretion of ascorbic acid due to the chronic gastritis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with intestinal metaplasia have lower serum levels of ascorbic acid compared with controls [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Low levels of dietary ascorbic acid can lead to progression of precancerous lesions to dysplasia and cancer in high risk individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/26\">",
"       26",
"      </a>",
"      ]. Ascorbic acid ingestion was associated with a decreased risk of gastric cancer in case control studies [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/27,28\">",
"       27,28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     H. pylori strain differences",
"    </span>",
"    &nbsp;&mdash;&nbsp;The strain of",
"    <em>",
"     H. pylori",
"    </em>",
"    also may be a determinant of it potential to cause cancer or ulcer disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/44/4809?source=see_link&amp;anchor=H5#H5\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\", section on 'Bacterial strain differences'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5255416\">",
"    <span class=\"h3\">",
"     Interaction between H. pylori and diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;The consumption of salted food appears to increase the possibility of persistent infection with",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In addition, a synergistic interaction between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and salted food intake to increase the risk of gastric cancer has also been reported in case-control studies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/16/43271?source=see_link\">",
"     \"Bacteriology and epidemiology of Helicobacter pylori infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Animal studies also suggest that",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and high-salt intake act synergistically to promote the development of gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/33\">",
"     33",
"    </a>",
"    ]. In one study in Mongolian gerbils, expression of the pro-inflammatory mediators, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), were significantly up-regulated. Both iNOS and COX-2 overexpression have been demonstrated in gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/34-37\">",
"     34-37",
"    </a>",
"    ]. On the other hand, there was no significant effect on these mediators in non-infected animals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies suggest that",
"    <em>",
"     H. pylori",
"    </em>",
"    might affect other dietary associations with gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/39\">",
"     39",
"    </a>",
"    ]. The potential protective effect of dietary antioxidants such as vitamins C and E and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    seems to be stronger in those infected by",
"    <em>",
"     H. pylori",
"    </em>",
"    , even though results are inconsistent. The risk of gastric cancer associated with red meat, processed meat, or endogenous formation of nitrosamines appears to be observed only in patients infected with",
"    <em>",
"     H. pylori",
"    </em>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Apoptotic pathways",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two processes important in carcinogenesis are apoptosis (programmed cell death) and hyperproliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/40\">",
"     40",
"    </a>",
"    ]. Following severe DNA damage, apoptosis occurs as a protective mechanism to prevent replication of mutated DNA. Atrophic gastritis with destruction and loss of the glands could be the result of apoptosis. This hypothesis is supported by the finding of an increased rate of antral apoptosis in",
"    <em>",
"     H. pylori",
"    </em>",
"    -infected subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/41,42\">",
"     41,42",
"    </a>",
"    ] which returns to normal following eradication therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which",
"    <em>",
"     H. pylori",
"    </em>",
"    induces apoptosis is unclear. One study suggested that the organism causes apoptosis by both direct and indirect mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/43\">",
"     43",
"    </a>",
"    ]. In the latter circumstance,",
"    <em>",
"     H. pylori",
"    </em>",
"    appears to sensitize epithelial cells for apoptosis which is induced by proinflammatory stimuli (eg, tumor necrosis factor alpha).",
"    <em>",
"     H. pylori",
"    </em>",
"    enhances expression of the Fas receptor on gastric epithelial cells and may mediate apoptosis through signaling mechanisms related to the Fas death receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Proliferating cells may be resistant to apoptosis. This would upset the balance between cell growth and death, leading to hyperproliferation and the promotion of neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/45\">",
"     45",
"    </a>",
"    ]. There is evidence of an increased amount of the antiapoptosis protein, Bcl-2, in the setting of gastric dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/46\">",
"     46",
"    </a>",
"    ]. Other reports have found that apoptosis may be due to plasminogen activator inhibitor (PAI)-2, the expression of which is increased by",
"    <em>",
"     H. pylori",
"    </em>",
"    . PAI-2 is increased in gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/47\">",
"     47",
"    </a>",
"    ]. An uncoupling of epithelial proliferation and apoptosis may be a strain-dependent phenomenon. Hyperproliferation has been seen in CagA-infected patients in whom apoptosis is not increased [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Cytokine polymorphisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain polymorphisms in IL-1 beta and other cytokines may confer an increased susceptibility to non cardia gastric adenocarcinoma caused by",
"    <em>",
"     H. pylori",
"    </em>",
"    by inducing a hypochlorhydric and atrophic response to",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/49-54\">",
"     49-54",
"    </a>",
"    ]. An illustrative study compared IL-1 beta polymorphisms in 393 patients with gastric cancer with 430 controls [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/49\">",
"     49",
"    </a>",
"    ]. Two specific polymorphisms (IL-1B-31T and IL-1RN*2) were associated with low acid secretion and gastric atrophy. The authors concluded that 38 percent of",
"    <em>",
"     H. pylori",
"    </em>",
"    -related gastric cancer could be attributed to the presence of these alleles. IL-1 beta, a potent inhibitor of gastric acid secretion, is upregulated by the presence of H. pylori.",
"   </p>",
"   <p>",
"    A similar report compared polymorphisms in genes for several cytokines in patients with a variety of gastric and esophageal malignancies with a control population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/50\">",
"     50",
"    </a>",
"    ]. Proinflammatory genotypes of tumor necrosis factor alpha and IL-10 were associated with more than a doubling of the risk of non cardia gastric cancer. Carriage of multiple proinflammatory polymorphisms of IL-1 beta, IL-1 receptor antagonist, tumor necrosis factor A, and IL-10 conferred even greater risk (OR 2.8 for one, 5.4 for two, and 27.3 for more than three). By contrast, these polymorphisms were not associated with an increased risk of esophageal or gastric cardia cancers.",
"   </p>",
"   <p>",
"    These data suggest that gene polymorphisms influence cytokine expression, gastric inflammation, and risk for development of precancerous lesions in those infected with",
"    <em>",
"     H. pylori",
"    </em>",
"    . Infection with certain virulent bacterial strain types augments inflammation and cancer risk, supporting a complex interaction between host and bacterial in the development of GI pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3007203\">",
"    <span class=\"h3\">",
"     Hemoglobin A1c",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other host factors may contribute to the development of gastric cancer in",
"    <em>",
"     H. pylori",
"    </em>",
"    -infected individuals. A study of 2603 Japanese subjects aged &ge;40 years were stratified into four groups according to baseline hemoglobin A1c (HbA1c) levels (&le;4.9 percent, 5.0 to 5.9 percent, 6.0 to 6.9 percent, and &ge;7.0 percent) and followed up prospectively for 14 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/56\">",
"     56",
"    </a>",
"    ]. During the follow-up, 97 subjects developed gastric cancer. The age- and sex-adjusted incidence of gastric cancer significantly increased in the two higher HbA1c level groups. This association remained substantially unchanged even after adjusting for the confounding factors including",
"    <em>",
"     H. pylori",
"    </em>",
"    seropositivity. Among subjects who had both high HbA1c levels (&ge;6.0 percent) and",
"    <em>",
"     H. pylori",
"    </em>",
"    infection, the risk of gastric cancer was dramatically elevated. The mechanism whereby elevated blood sugar enhances the risk of gastric cancer is unclear but the risk of other cancers has been shown to be increased in those with diabetes mellitus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Importance of other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric carcinogenesis cannot be explained by",
"    <em>",
"     H. pylori",
"    </em>",
"    infection alone as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Only a small fraction of",
"      <em>",
"       H. pylori",
"      </em>",
"      -infected individuals develop cancer.",
"     </li>",
"     <li>",
"      The incidence of gastric cancer varies regionally despite similar prevalences of",
"      <em>",
"       H. pylori",
"      </em>",
"      worldwide [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/5,57\">",
"       5,57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The gastric cancer risk is not increased in patients with",
"      <em>",
"       H. pylori",
"      </em>",
"      -related duodenal ulcer disease. To the contrary, in a study from Sweden evaluating the incidence of gastric cancer in patients previously hospitalized for gastric or duodenal ulcer, the incidence was significantly",
"      <strong>",
"       decreased",
"      </strong>",
"      in the group with duodenal ulcer (standardized incidence ratio 0.6 versus 1.8 in those with gastric ulcer) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The explanation for this protective feature of",
"    <em>",
"     H. pylori",
"    </em>",
"    -induced duodenal ulcer is unclear. One theory is that atrophic gastritis, which is an early step in gastric carcinogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/59\">",
"     59",
"    </a>",
"    ], occurs with",
"    <em>",
"     H. pylori",
"    </em>",
"    -related gastric ulcers but not duodenal ulcers. Host factors may influence the susceptibility to",
"    <em>",
"     H. pylori",
"    </em>",
"    -induced gastric atrophy. Support for the relationship between atrophic gastritis and",
"    <em>",
"     H. pylori",
"    </em>",
"    infection was derived from a study which found that an HLA-DQA1 allele appeared to contribute to resistance against",
"    <em>",
"     H. pylori",
"    </em>",
"    -associated gastric atrophy and gastric adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Strain differences may also provide some explanation. As noted above, infection with",
"    <em>",
"     H. pylori",
"    </em>",
"    that contain a duodenal ulcer promoting gene, DupA, appears to lower the risk for gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/61\">",
"     61",
"    </a>",
"    ]. Another hypothesis is that duodenal ulcer may be associated with an increased level of ascorbic acid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/62\">",
"     62",
"    </a>",
"    ], which may protect against subsequent development of gastric cancer.",
"   </p>",
"   <p>",
"    Finally, as noted above, cytokine polymorphisms associated with cancer result in more diffuse gastritis and low acid secretion, gastric histology, and physiology unusual in duodenal ulcer patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Role of family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A family history has been associated with a 1.5- to 3-fold increased risk of gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Whether this reflects clustering of",
"    <em>",
"     H. pylori",
"    </em>",
"    within families with gastric cancer is uncertain. A case-control study suggested that the two risks were independent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/65\">",
"     65",
"    </a>",
"    ]. Relatives of patients with gastric cancer are more likely to be infected by",
"    <em>",
"     H. pylori",
"    </em>",
"    than unrelated controls. Infected relatives are also more likely to have low gastric acid secretion, a known",
"    <span class=\"nowrap\">",
"     marker/risk",
"    </span>",
"    factor for gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/66\">",
"     66",
"    </a>",
"    ]. As noted above, this observation may be explained by hereditary differences in inflammatory cytokine polymorphisms that determine a host's acid secretory profile and the degree and distribution of gastric inflammation that results from",
"    <em>",
"     H. pylori",
"    </em>",
"    infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Does treatment reduce risk of gastric cancer?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eradication of",
"    <em>",
"     H. pylori",
"    </em>",
"    appears to reduce the risk of gastric cancer in high-risk populations. A meta-analysis that included seven controlled trials (all in areas with a high incidence of gastric cancer) found significantly lower rates of gastric cancer (1.1 versus 1.7 percent) in patients randomized to eradication (RR 0.65, 95% CI 0.43-0.98) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/67\">",
"     67",
"    </a>",
"    ]. In a subsequent placebo-controlled trial in China in which 3365 subjects were randomly assigned to receive two weeks of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    to eradicate",
"    <em>",
"     H. pylori",
"    </em>",
"    , at the end of 14.7 years of follow-up, there was a significant reduction in the incidence of gastric cancer in the patients who underwent eradication (3.0 versus 4.6 percent, OR 0.61, 95% CI 0.38-0.96) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <em>",
"     H. pylori",
"    </em>",
"    eradication has also been evaluated in the setting of early gastric cancer (EGC). These data suggest that",
"    <em>",
"     H. pylori",
"    </em>",
"    is associated with EGC and its eradication can reduce rates of metachronous recurrence following resection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4842?source=see_link&amp;anchor=H757936026#H757936026\">",
"     \"Early gastric cancer: Treatment, natural history, and prognosis\", section on 'Anti-Helicobacter therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even if treatment does reduce the gastric cancer risk, difficulties with screening for",
"    <em>",
"     H. pylori",
"    </em>",
"    and treatment arise. The cost of screening and treating would be large given the worldwide prevalence of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection. Nevertheless, one study that economically modeled the cost of screening per year of life saved estimated that, in selected populations such as Japanese American, serologic screening for",
"    <em>",
"     H. pylori",
"    </em>",
"    beginning at age 50 was more beneficial than breast cancer screening [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/69\">",
"     69",
"    </a>",
"    ]. Another cost-effectiveness analysis concluded that screening and treatment could be cost-effective if the cancer risk following eradication could be restored to that of a population that had never been infected with",
"    <em>",
"     H. pylori",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of major medical organizations have issued guidelines related to",
"    <em>",
"     H. pylori",
"    </em>",
"    screening and eradication in high-risk populations. As examples, Asian-Pacific guidelines and European guidelines support population-based screening in high-risk settings [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. In contrast, guidelines from the American College of Gastroenterology also describe high-risk populations but consider strategies for screening such groups as controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/73\">",
"     73",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6983?source=see_link\">",
"     \"Screening and prevention of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, at present, there is still insufficient data to recommend screening asymptomatic patients for",
"    <em>",
"     H. pylori",
"    </em>",
"    to prevent gastric cancer on a widespread basis. However, decisions to screen based on risk factors, such as race, diet, and family history, can be made on an individual basis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     GASTRIC LYMPHOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary gastric lymphoma accounts for 3 percent of gastric neoplasms and 10 percent of lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/74\">",
"     74",
"    </a>",
"    ]. The stomach is the most common extranodal site of lymphoma. Lymphoma can arise from lymph nodes or mucosal areas; the latter is referred to as a mucosa (gut)-associated lymphoid tissue tumor (MALToma, MALT-type lymphoma, or MALT lymphoma, now called extranodal marginal zone B-cell lymphoma of MALT type in the REAL classification), of which the stomach is the most common site (",
"    <a class=\"graphic graphic_picture graphicRef68386 graphicRef59651 \" href=\"UTD.htm?32/34/33322\">",
"     picture 2A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33416?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of splenic marginal zone lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Presenting symptoms of gastric lymphoma include epigastric pain (which is the most common), weight loss, anorexia, vomiting, melena, hematemesis, back pain, and nausea. The diagnosis is based upon histologic criteria and the presence of B-cell markers by immunocytochemistry. Histology shows lymphoepithelial changes, polymorphic cellular content, centrocyte like cells, and reactive germinal centers. High-grade lymphoma (eg, diffuse large B-cell lymphoma) is distinguished from low-grade disease when the number of large blast cells exceeds 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The normal stomach does not contain significant lymphoid tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/76\">",
"     76",
"    </a>",
"    ]. However,",
"    <em>",
"     H. pylori",
"    </em>",
"    -induced gastritis leads to an aggregation of CD4+ lymphocytes and B cells in the gastric lamina propria. Antigen presentation occurs followed by T cell activation, B cell proliferation, and lymphoid follicle formation.",
"   </p>",
"   <p>",
"    The gastric follicle resembles those seen in the ileum in Peyer's patches [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/77\">",
"     77",
"    </a>",
"    ]. A follicle is characterized by a center consisting of centroblasts and centrocytes. The center is surrounded by a B cell zone referred to as a mantle. The mantle is enclosed by a marginal zone, which is also comprised of B cells.",
"   </p>",
"   <p>",
"    A hypothesis has been proposed to describe the development of gastric B-cell lymphoma of marginal zone type (previously called low-grade MALToma). The antigen-presenting cell interacts with a CD4+ T-cell. The activated T-cell then binds to a B-cell with an aberrant ability for unsuppressed proliferation. A population of centrocyte-like B-cells arise to form the marginal zone, thereby representing low-grade lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. This hypothesis was supported in a report of two patients with gastric MALToma who had a previous gastric biopsy several years before the onset of lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/79\">",
"     79",
"    </a>",
"    ]. The lymphomas were shown to arise from a B cell clone at the site of chronic gastritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     H. pylori infection and MALToma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated an association between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and MALToma, and have begun to elucidate the mechanisms underlying this association [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/80-86\">",
"     80-86",
"    </a>",
"    ]. As with gastric cancer, the development of MALToma may be related to specific",
"    <em>",
"     H. pylori",
"    </em>",
"    strains expressing the CagA protein. In one report, for example, serum IgG antibody to CagA was much more common in patients with MALToma than an",
"    <em>",
"     H. pylori",
"    </em>",
"    -infected control group (95 versus 67 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/82\">",
"     82",
"    </a>",
"    ]. It is also possible that other species of Helicobacter are involved in the development of gastric MALT lymphomas. As an example, an association with H. heilmannii has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/85,87\">",
"     85,87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Efficacy of anti-H. pylori therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most dramatic evidence supporting a pathogenetic role for",
"    <em>",
"     H. pylori",
"    </em>",
"    in MALToma is remission of the tumor following eradication of",
"    <em>",
"     H. pylori",
"    </em>",
"    with antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/88-94\">",
"     88-94",
"    </a>",
"    ]. The role of",
"    <em>",
"     H. pylori",
"    </em>",
"    treatment in the management of gastric lymphoma is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/53/3930?source=see_link&amp;anchor=H5#H5\">",
"     \"Management of gastrointestinal lymphomas\", section on 'Early stage H pylori positive'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COLON CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and colorectal polyps and colorectal cancer has been described but remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/95-104\">",
"     95-104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The biologic basis for such an association is uncertain. One possibility is elevated serum gastrin levels in patients with",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/96\">",
"     96",
"    </a>",
"    ]. Gastrin receptors have been identified on a variety of colon cancer cell lines, and endogenous serum gastrin levels have been correlated with the risk of colonic neoplasms. However, one report found that serum gastrin levels and",
"    <em>",
"     H. pylori",
"    </em>",
"    infection were not associated with an increased risk for recurrent colorectal adenoma development [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/102\">",
"     102",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25751?source=see_link\">",
"     \"Physiology of gastrin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PANCREATIC CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and pancreatic cancer has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/105-108\">",
"     105-108",
"    </a>",
"    ]. One report found that the risk for pancreatic cancer was greatest in patients infected with CagA positive strains of",
"    <em>",
"     H. pylori",
"    </em>",
"    . Another report found an association between colonization with non-CagA",
"    <em>",
"     H. pylori",
"    </em>",
"    strains and pancreatic cancer in patients with non-O blood types; no association was found in patients with non-O blood types infected with CagA positive",
"    <em>",
"     H. pylori",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/107\">",
"     107",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'H. pylori strain differences'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A possible mechanism proposed for the association of pancreatic cancer and",
"    <em>",
"     H. pylori",
"    </em>",
"    is the link between pancreatic cancer and chronic hyperacidity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/36/2634/abstract/109\">",
"     109",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'H. pylori strain differences'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27866?source=see_link\">",
"     \"Epidemiology and risk factors for exocrine pancreatic cancer\"",
"    </a>",
"    .) Additional studies are needed to confirm the association of pancreatic cancer and",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and also to better support the putative role of hyperacidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/31/19954?source=see_link\">",
"       \"Patient information: H. pylori infection (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/58/14242?source=see_link\">",
"       \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 36 and 47 percent of all gastric cancers in developed and developing countries, respectively, are solely attributable to",
"      <em>",
"       H. pylori",
"      </em>",
"      infection. This accounts for almost 350,000 gastric cancers annually worldwide.",
"     </li>",
"     <li>",
"      Several hypotheses have been proposed to explain the role of",
"      <em>",
"       H. pylori",
"      </em>",
"      in carcinogenesis, although the exact mechanism is incompletely understood. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Role of H. pylori in carcinogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple studies have demonstrated an association between",
"      <em>",
"       H. pylori",
"      </em>",
"      infection and MALToma. The most dramatic evidence supporting a pathogenetic role for",
"      <em>",
"       H. pylori",
"      </em>",
"      in MALToma is remission of the tumor following eradication of",
"      <em>",
"       H. pylori",
"      </em>",
"      with antibiotic therapy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Gastric lymphoma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/1\">",
"      Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/2\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/3\">",
"      Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/4\">",
"      Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/5\">",
"      Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/6\">",
"      Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/7\">",
"      Siurala M, Varis K, Wiljasalo M. Studies of patients with atrophic gastritis: a 10-15-year follow-up. Scand J Gastroenterol 1966; 1:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/8\">",
"      Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/9\">",
"      Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/10\">",
"      Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/11\">",
"      Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/12\">",
"      Persson C, Jia Y, Pettersson H, et al. H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS One 2011; 6:e17404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/13\">",
"      Hansson LR, Engstrand L, Nyr&eacute;n O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995; 109:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/14\">",
"      Parsonnet J, Vandersteen D, Goates J, et al. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/15\">",
"      Guarner J, Mohar A, Parsonnet J, Halperin D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 1993; 71:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/16\">",
"      An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993; 341:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/17\">",
"      Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/18\">",
"      Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/19\">",
"      Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/20\">",
"      Hansen S, Melby KK, Aase S, et al. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999; 34:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/21\">",
"      Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/22\">",
"      Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005; 21:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/23\">",
"      Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306:1568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/24\">",
"      Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989; 97:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/25\">",
"      Plasma vitamin concentrations in patients with intestinal metaplasia and in controls. UK Subgroup of the ECP-EURONUT-IM Study Group. Eur J Cancer Prev 1992; 1:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/26\">",
"      You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/27\">",
"      Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991; 53:270S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/28\">",
"      Feiz HR, Mobarhan S. Does vitamin C intake slow the progression of gastric cancer in Helicobacter pylori-infected populations? Nutr Rev 2002; 60:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/29\">",
"      Tsugane S, Tei Y, Takahashi T, et al. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 1994; 85:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/30\">",
"      Fox JG, Dangler CA, Taylor NS, et al. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999; 59:4823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/31\">",
"      Lee SA, Kang D, Shim KN, et al. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/32\">",
"      Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer 2004; 7:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/33\">",
"      Nozaki K, Shimizu N, Inada K, et al. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002; 93:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/34\">",
"      Yu LZ, Gao HJ, Bai JF, et al. Expression of COX-2 proteins in gastric mucosal lesions. World J Gastroenterol 2004; 10:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/35\">",
"      van Rees BP, Saukkonen K, Ristim&auml;ki A, et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 2002; 196:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/36\">",
"      Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000; 6:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/37\">",
"      Kaise M, Miwa J, Suzuki N, et al. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma. Eur J Gastroenterol Hepatol 2007; 19:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/38\">",
"      Toyoda T, Tsukamoto T, Hirano N, et al. Synergistic upregulation of inducible nitric oxide synthase and cyclooxygenase-2 in gastric mucosa of Mongolian gerbils by a high-salt diet and Helicobacter pylori infection. Histol Histopathol 2008; 23:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/39\">",
"      Gonz&aacute;lez CA, L&oacute;pez-Carrillo L. Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 2010; 45:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/40\">",
"      Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/41\">",
"      Moss SF, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/42\">",
"      Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/43\">",
"      Wagner S, Beil W, Westermann J, et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology 1997; 113:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/44\">",
"      Jones NL, Day AS, Jennings HA, Sherman PM. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 1999; 67:4237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/45\">",
"      Correa P, Miller MJ. Helicobacter pylori and gastric atrophy--cancer paradoxes. J Natl Cancer Inst 1995; 87:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/46\">",
"      Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994; 73:2900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/47\">",
"      Varro A, Noble PJ, Pritchard DM, et al. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappaB and RhoA: implications for invasion and apoptosis. Cancer Res 2004; 64:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/48\">",
"      Peek RM Jr, Moss SF, Tham KT, et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/49\">",
"      El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/50\">",
"      El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/51\">",
"      Garza-Gonz&aacute;lez E, Bosques-Padilla FJ, El-Omar E, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/52\">",
"      Furuta T, El-Omar EM, Xiao F, et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/53\">",
"      El-Omar EM, Carrington M, Chow WH, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/54\">",
"      Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/55\">",
"      Rad R, Dossumbekova A, Neu B, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/56\">",
"      Ikeda F, Doi Y, Yonemoto K, et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009; 136:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/57\">",
"      Sierra R, Mu&ntilde;oz N, Pe&ntilde;a AS, et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev 1992; 1:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/58\">",
"      Hansson LE, Nyr&eacute;n O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/59\">",
"      Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993; 4:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/60\">",
"      Azuma T, Ito S, Sato F, et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998; 82:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/61\">",
"      Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/62\">",
"      Rood JC, Ruiz B, Fontham ET, et al. Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer 1994; 22:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/63\">",
"      La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992; 70:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/64\">",
"      Inoue M, Tajima K, Yamamura Y, et al. Family history and subsite of gastric cancer: data from a case-referent study in Japan. Int J Cancer 1998; 76:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/65\">",
"      Brenner H, Arndt V, St&uuml;rmer T, et al. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/66\">",
"      El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/67\">",
"      Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009; 151:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/68\">",
"      Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/69\">",
"      Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/70\">",
"      Fendrick AM, Chernew ME, Hirth RA, et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999; 159:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/71\">",
"      Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008; 103:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/72\">",
"      Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/73\">",
"      Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/74\">",
"      Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29:252.",
"     </a>",
"    </li>",
"    <li>",
"     Isaacson PG. Gastrointestinal lymphomas and lymphoid hyperplasias. In: Neoplastic Haematolpathology, Knowles DM (Ed), Williams &amp; Wilkins, Baltimore 1992. p.953.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/76\">",
"      Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367:425.",
"     </a>",
"    </li>",
"    <li>",
"     Lydyard P, Grossi C. Secondary lymphoid organs and tissues. In: Immunology, 4th ed, Roitt I, Brostoff J, Male D (Eds), Mosby, London 1996. p.31.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/78\">",
"      D'Elios MM, Amedei A, Manghetti M, et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. Gastroenterology 1999; 117:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/79\">",
"      Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998; 338:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/80\">",
"      Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/81\">",
"      Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/82\">",
"      Eck M, Schmausser B, Haas R, et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112:1482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/83\">",
"      Chang CS, Chen LT, Yang JC, et al. Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology 1999; 117:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/84\">",
"      Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999; 104:R49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/85\">",
"      Stolte M, Kroher G, Meining A, et al. A comparison of Helicobacter pylori and H. heilmannii gastritis. A matched control study involving 404 patients. Scand J Gastroenterol 1997; 32:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/86\">",
"      Lin WC, Tsai HF, Kuo SH, et al. Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res 2010; 70:5740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/87\">",
"      Morgner A, Lehn N, Andersen LP, et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 2000; 118:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/88\">",
"      Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/89\">",
"      Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996; 87:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/90\">",
"      Weber DM, Dimopoulos MA, Anandu DP, et al. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 1994; 107:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/91\">",
"      Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/92\">",
"      Carlson SJ, Yokoo H, Vanagunas A. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. JAMA 1996; 275:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/93\">",
"      Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999; 131:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/94\">",
"      Fischbach W, Goebeler-Kolve ME, Dragosics B, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/95\">",
"      Breuer-Katschinski B, Nemes K, Marr A, et al. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999; 60:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/96\">",
"      Aydin A, Karasu Z, Zeytinoglu A, et al. Colorectal adenomateous polyps and Helicobacter pylori infection. Am J Gastroenterol 1999; 94:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/97\">",
"      Meucci G, Tatarella M, Vecchi M, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997; 25:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/98\">",
"      Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96:3406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/99\">",
"      Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/100\">",
"      Moss SF, Neugut AI, Garbowski GC, et al. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995; 87:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/101\">",
"      Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/102\">",
"      Robertson DJ, Sandler RS, Ahnen DJ, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol 2009; 7:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/103\">",
"      Zhang Y, Hoffmeister M, Weck MN, et al. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012; 175:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/104\">",
"      Hong SN, Lee SM, Kim JH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012; 57:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/105\">",
"      Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001; 93:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/106\">",
"      Raderer M, Wrba F, Kornek G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/107\">",
"      Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010; 102:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/108\">",
"      Trikudanathan G, Philip A, Dasanu CA, Baker WL. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 2011; 12:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/36/2634/abstract/109\">",
"      Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003; 95:948.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2514 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-382E3F64B8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2634=[""].join("\n");
var outline_f2_36_2634=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GASTRIC CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Role of H. pylori in carcinogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Neutrophil activation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Hypochlorhydria and ascorbic acid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - H. pylori strain differences",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5255416\">",
"      - Interaction between H. pylori and diet",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Apoptotic pathways",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Cytokine polymorphisms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3007203\">",
"      - Hemoglobin A1c",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Importance of other factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Role of family history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Does treatment reduce risk of gastric cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GASTRIC LYMPHOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      H. pylori infection and MALToma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Efficacy of anti-H. pylori therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COLON CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PANCREATIC CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2514\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2514|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?10/39/10878\" title=\"algorithm 1\">",
"      H pylori and gastric CA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2514|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/24/17802\" title=\"picture 1\">",
"      Gastritis intestinal metaplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/1/22552\" title=\"picture 2A\">",
"      Gastric MALToma Low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/62/15335\" title=\"picture 2B\">",
"      Gastric MALToma B cell stain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/16/43271?source=related_link\">",
"      Bacteriology and epidemiology of Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33416?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of splenic marginal zone lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=related_link\">",
"      Clinical presentation and diagnosis of primary gastrointestinal lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4842?source=related_link\">",
"      Early gastric cancer: Treatment, natural history, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27866?source=related_link\">",
"      Epidemiology and risk factors for exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4661?source=related_link\">",
"      Epidemiology of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/53/3930?source=related_link\">",
"      Management of gastrointestinal lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=related_link\">",
"      Pathology and molecular pathogenesis of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/44/4809?source=related_link\">",
"      Pathophysiology of and immune response to Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/31/19954?source=related_link\">",
"      Patient information: H. pylori infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/58/14242?source=related_link\">",
"      Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25751?source=related_link\">",
"      Physiology of gastrin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6983?source=related_link\">",
"      Screening and prevention of gastric cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_36_2635="Contraindications vaginal hyst";
var content_f2_36_2635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contraindications to vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Suspicious adnexal mass that is high risk for cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Known cancers where intra-peritoneal assessment and treatment are required",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Known pelvic adhesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Access to uterine arteries is limited by the size of the uterus in relation to the pelvic size",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Inability to properly position the patient for vaginal access",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Example: severe arthritis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2635=[""].join("\n");
var outline_f2_36_2635=null;
var title_f2_36_2636="Etiology third nerve palsy";
var content_f2_36_2636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of third nerve palsy in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Location",
"      </td>",
"      <td class=\"subtitle1\">",
"       Cause",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"7\">",
"       Nuclear or fascicular",
"      </td>",
"      <td>",
"       Congenital",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Demyelinating",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ischemic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vascular",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neoplastic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Traumatic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"5\">",
"       Subarachnoid space",
"      </td>",
"      <td>",
"       Aneurysm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carcinomatous meningitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Infectious",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neoplastic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"7\">",
"       Cavernous sinus",
"      </td>",
"      <td>",
"       Cavernous sinus thrombosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cavernous sinus fistula",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neoplastic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ischemic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Infectious",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Internal carotid artery aneurysm or dissection",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"4\">",
"       Orbital",
"      </td>",
"      <td>",
"       Neoplastic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Infectious",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Traumatic",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified and reprinted with permission from Lee AG and Brazis PW. Clinical Pathways in Neuro-Ophthalmology: An Evidence-based Approach, 2nd ed,&nbsp;Thieme, New York 2003.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2636=[""].join("\n");
var outline_f2_36_2636=null;
var title_f2_36_2637="Clinical indications of possible antibody defects";
var content_f2_36_2637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F60473&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F60473&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infections that warrant an evaluation of antibody-mediated immunity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        Indications",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Number of episodes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        Allergy/Immunology Clinic LSUHSC, New Orleans",
"       </td>",
"       <td class=\"subtitle2\">",
"        Jeffrey Modell Foundation*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        2-5 years of age",
"       </td>",
"       <td class=\"subtitle3\">",
"        &gt;5 years of age",
"       </td>",
"       <td class=\"subtitle3\">",
"        Any age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Respiratory infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        URI treated with antibiotics in last 12 months",
"       </td>",
"       <td>",
"        &ge;4",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Otitis treated with antibiotics (per year)",
"       </td>",
"       <td>",
"        &ge;3&bull;",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sinusitis episodes (per year)",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic, treatment-resistant sinusitis (&gt;1 mo)",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumonias (per year)",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Invasive infections (sepsis, meningitis, osteomyelitis)",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Severe invasive infections",
"       </td>",
"       <td>",
"        &gt;1",
"       </td>",
"       <td>",
"        &gt;1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Gastrointestinal infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic diarrhea due to rotavirus, other",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic/recurrent Giardia lamblia infection",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Antibiotic use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Need for preventive antibiotic use",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic antibiotic use without effect",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Longer than 2 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Need for IV antibiotics to clear infection",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &ge;1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * This information is from the The Jeffrey Modell Foundation Website at file://www.info4pi.org",
"     <br>",
"      &bull; After placement of ventilation tubes",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Sorensen, RU, Moore, C. Peds Clin N A 2000; 42:1225.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2637=[""].join("\n");
var outline_f2_36_2637=null;
var title_f2_36_2638="Single drug in whites";
var content_f2_36_2638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F77960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F77960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 484px\">",
"   <div class=\"ttl\">",
"    Antihypertensive response to different drugs in whites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 464px; height: 224px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Response rates to single drug therapy for hypertension in whites under the age of 60. There were no significant differences in response, except that hydrochlorothiazide (HCTZ) appeared to be least effective. A response was defined as a diastolic pressure below 90 mmHg at the end of the titration phase and below 95 mmHg at one year. The pattern of response was similar but the success rate for each drug was reduced by five to 15 percent if goal diastolic pressure were less than 90 mmHg at one year. There were between 30 and 39 patients in each group.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Materson, BJ, Reda, DJ, Cushman, WC, et al, N Engl J Med 1993; 328:914. Correction and additional data: Am J Hypertens 1995; 8:189.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_36_2638=[""].join("\n");
var outline_f2_36_2638=null;
var title_f2_36_2639="Contents: Esophageal disease";
var content_f2_36_2639=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?3/12/3278\">",
"       Gastroenterology and Hepatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Esophageal disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Esophageal disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Benign diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/56/41861\">",
"           Acute esophageal necrosis (black esophagus)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/18/2346\">",
"           Benign lesions of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/58/29606\">",
"           Boerhaave's syndrome: Effort rupture of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/38/40551\">",
"           Caustic esophageal injury in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/57/10137\">",
"           Complications of endoscopic esophageal stricture dilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/34/12838\">",
"           Esophageal webs and rings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/19/21814\">",
"           Globus sensation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/54/21353\">",
"           Ingested foreign bodies and food impactions in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/19/43317\">",
"           Mallory-Weiss syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/24/39305\">",
"           Management of benign esophageal strictures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/13/37078\">",
"           Medication-induced esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/45/32474\">",
"           Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/16/44297\">",
"           Treatment of eosinophilic esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/52/29512\">",
"           Zenker's diverticulum",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Clinical pathological cases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/55/11124\">",
"           Clinical pathological cases in gastroenterology: Esophagus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastroesophageal reflux disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/18/17706\">",
"           Approach to refractory gastroesophageal reflux disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/56/15240\">",
"           Chest pain of esophageal origin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/41/22168\">",
"           Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/53/1879\">",
"           Clinical manifestations, diagnosis, and treatment of non-acid reflux",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/51/19253\">",
"           Complications of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/5/25688\">",
"           Endoscopic therapy for gastroesophageal reflux disease: Sewing and full-thickness plication techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/40/26247\">",
"           Esophageal multichannel intraluminal impedance testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/22/7527\">",
"           Hiatus hernia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/53/42840\">",
"           Medical management of gastroesophageal reflux disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/38/13928\">",
"           Pathophysiology of reflux esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/62/12263\">",
"           Radiofrequency treatment for gastroesophageal reflux disease (the Stretta������ procedure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/57/42905\">",
"           Surgical management of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/17/29972\">",
"           Clinical manifestations of oropharyngeal and esophageal candidiasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/31/6647\">",
"           Herpes simplex virus infection of the esophagus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Motility",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/26/14759\">",
"           Clinical manifestations and diagnosis of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/25/24985\">",
"           Diabetic autonomic neuropathy of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/38/17000\">",
"           Diagnosis and treatment of oropharyngeal dysphagia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/50/13096\">",
"           Diffuse esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/17/12569\">",
"           Evaluation of dysphagia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/35/41529\">",
"           Gastrointestinal manifestations of systemic sclerosis (scleroderma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/23/17785\">",
"           High resolution manometry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/11/16568\">",
"           Motility testing: When does it help?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/39/18039\">",
"           Overview of the treatment of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/63/2037\">",
"           Pathogenesis and clinical manifestations of oropharyngeal dysphagia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/7/43124\">",
"           Pathophysiology and etiology of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/32/12810\">",
"           Pneumatic dilation and botulinum toxin injection for achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/9/11415\">",
"           Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neoplastic diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/34/33321\">",
"           Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/27/13750\">",
"           Autofluorescence endoscopy for Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/10/44202\">",
"           Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/45/7898\">",
"           Diagnosis and staging of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/1/42006\">",
"           Endoscopic palliation of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/35/35386\">",
"           Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/8/1161\">",
"           Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/31/32250\">",
"           Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/7/34938\">",
"           Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/61/35802\">",
"           Management of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30106\">",
"           Management of locally advanced unresectable esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/40/29316\">",
"           Narrow band imaging in Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/12/8391\">",
"           Pathogenesis of Barrett's esophagus and its malignant transformation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/39/2676\">",
"           Patient information: Barrett's esophagus (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/27/26039\">",
"           Photodynamic therapy for ablation of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/31/39418\">",
"           Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/53/41817\">",
"           Radiofrequency ablation for Barrett's esophagus",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-91FD7EC159-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f2_36_2639=[""].join("\n");
var outline_f2_36_2639=null;
